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This thesis is presented in two volumes; the research component (Volume 
One) and the clinical component (Volume Two). 
Volume One presents three research papers focusing on understanding 
interventions and change processes for people with severe and enduring mental 
health problems.  The first paper is a meta-analysis evaluating the use of Acceptance 
and Commitment Therapy for people with severe and enduring mental health 
problems. The second is an empirical study examining the role of shame and 
psychological flexibility in the relationship between mental health and substance use 
in people with severe and enduring mental health problems. The third is a report 
written to disseminate the research findings to the research participants and health 
care professionals.  
Volume Two consists of five clinical practice reports (CPRs). CPR one 
presents two formulations (using cognitive-behavioural and psychodynamic models) 
of a 71-year-old lady presenting with symptoms of obsessive-compulsive disorder. 
CPR two is a service evaluation examining how an older adult community mental 
health team worked with behaviour that challenges in care homes. CPR three 
describes a single case experiment evaluating a cognitive-behavioural intervention 
for a 43-year-old man diagnosed with obsessive-compulsive disorder. CPR four 
presents a case study of a compassion-focused intervention with a 25-year-old man 
presenting with shame and self-criticism within a community forensic learning 
disability service. The abstract of CPR five, an oral case presentation of a 40-year-
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Chapter I: Literature Review 
 
Acceptance and Commitment Therapy (ACT) for people with severe and enduring 






















Background: People with severe and enduring mental health problems (SMI; 
psychotic disorders, bipolar affective disorder and major depressive disorder) 
experience poorer outcomes across a range of psychological, social and physical 
domains. The current review aimed to establish whether Acceptance and 
Commitment Therapy (ACT) can improve outcomes for this client group.  
Method: Twelve randomised controlled trials including participants (N=470) 
with SMI were included in the review. Trials were assessed for methodological quality 
using Down’s and Black’s Quality Index. Data relating to four outcomes (psychotic 
symptoms, depression, psychological flexibility and rehospitalisation rate) were 
extracted and analysed using the “Meta” package from the R programme. 
Standardised mean differences were calculated for continuous outcomes and a 
relative risk ratio for incidence data.     
Results: Regarding depression outcomes, ACT significantly outperformed 
control conditions at both post-intervention (d=0.39) and follow-up (d=0.43). There 
was no significant difference in psychotic symptoms between ACT and control 
groups at either time point (d=-0.02 and d=0.16 respectively). A significant effect 
favouring ACT was observed for the psychological flexibility outcome at post 
intervention (d=0.33) but this was not maintained at follow-up (d=0.13). ACT did not 
significantly reduce the risk or rehospitalisation in comparison to control (RR=-0.36). 
 Conclusion: The number of trials included in the review was small and the 
evidence base has limitations. Despite this, the review provides preliminary evidence 
that ACT may be useful in decreasing depressive symptoms amongst people with 
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SMI and that this is maintained over time. It also suggested that ACT increases 
psychological flexibility in the short term. The results suggested that ACT did not 
improve symptoms of psychosis or reduce the risk of rehospitalisation compared to 




























2.1 Evidence-based interventions for severe and enduring mental health 
problems 
People who receive mental health services over long periods often present 
with a complex mix of psychological and social difficulties that can have significant 
and enduring negative impacts. People within this population often receive a 
diagnosis of ‘schizophrenia-related disorders’, ‘bipolar affective disorder’ and ‘major 
depressive disorder’. There is much debate in the literature about the value of 
diagnosis or labels such as ‘lifelong illness’, as well as the potential negative 
contribution of such diagnoses and labels to the continued difficulties (BPS, 2013). 
Whether or not a diagnosis is present, there is evidence that the difficulties 
experienced by this group can lead to substantial and sustained impairment in a 
person’s functioning (Charlwood, Mason, Goldacre et al., 1999). 
There is evidence to suggest that people with severe and enduring mental 
health problems (SMI) experience poorer outcomes across a range of psychological, 
social and physical domains. For example, people with SMI have an increased risk of 
suicide (Osborn, Levy, Nazareth & King, 2008) and an increased risk of symptom 
reoccurrence  and rehospitalisation, often associated with poor treatment 
engagement (Higashi, Medic, Littlewood et al., 2013). They may also be socially 
excluded and experience discrimination and loneliness (Fleischhacker, Arango, 
Arteel et al., 2014; Perese & Wolf, 2005).  Research suggests that people with SMI 
have a reduced life expectancy of up to 25 years compared to the general population 
(Chang, Hayes, Perera et al., 2011; Everett, Mahler, Biblin et al., 2008). This is 
largely due to poorer physical health (in part associated with the side effects of anti-
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psychotic mediations, such as weight gain), an increased risk of suicide and 
inadequate management or treatment (Fleischhacker et al., 2014).  
In order to improve outcomes for people with severe and enduring mental 
health problems, evidence-based interventions must be made available. Medication 
is often the first line of treatment for this population (British Medical Journal, 2017) 
and a combination of pharmacological and psychological treatment is recommended 
over either intervention in isolation (NICE, 2014b). When psychological interventions 
are offered, cognitive-behavioural therapy (CBT) is recommended (NICE, 2009; NICE, 
2014a; NICE, 2014b).  
Although CBT is recommended within clinical guidelines, there has been 
growing debate about the endorsement of CBT as an evidence-based approach 
(Thomas, 2015). This is primarily due to criticisms of the quality of research and 
claims that the evidence in favour of CBT has been “oversold” (McKenna & Kingdon, 
2014). For example, a meta-analysis of ‘well-controlled’ trials reported that CBT was 
ineffective at reducing symptoms or reoccurrence in schizophrenia, or at preventing 
reoccurrence in bipolar disorder (Lynch, Laws & McKenna, 2010). A Cochrane 
Review (Jones, Hacker, Cormack et al., 2012; pg. 2) evaluating CBT for 
schizophrenia concluded that there is “no clear and convincing advantage for 
cognitive behavioural therapy over other - and sometime much less sophisticated - 
therapies for people with schizophrenia.” 
Potentially as a result of concerns such as these, over recent years there has 
been growing interest in alternative treatment options for this client group. One such 
approach that has attracted attention is Acceptance and Commitment Therapy (ACT). 
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2.2 What is Acceptance and Commitment Therapy? 
Acceptance and commitment therapy uses a combination of acceptance, 
mindfulness and values-based therapeutic processes with the overall aim of 
increasing a person’s psychological flexibility and enabling them to engage in value-
driven activity (Hayes & Levin, 2012). Psychological flexibility is a process whereby 
an individual is able to mindfully observe inner and private experiences, such as 
thoughts, emotions and bodily experiences, and accept these as they are rather than 
attempting to change them (Hayes et al., 2013). It is understood that if an individual 
becomes ‘fused’ with such experiences and attempts to change or avoid them, their 
inward focus is increased and this can often prevent them from engaging in activities 
or pursuing goals that may be important to them (experiential avoidance; Pankey & 
Hayes, 2003). ACT first aims to clarify a person’s values and identify activities or 
behaviours that are in accordance with such values. Second, it promotes defusion 
from the inner experiences (i.e. observing a thought as just a product of our busy 
mind) to enable the individual to reduce avoidance and engage in value-driven 
activity.  Although a reduction in symptoms or a change in cognition may occur 
throughout an ACT intervention, symptom reduction is not the primary goal. ACT 
attempts to change a person’s relationship with their inner experience, rather than 
changing the experience itself (Pankey & Hayes, 2003).  
2.3 Acceptance and Commitment therapy with severe and enduring mental 
health problems 
ACT has been applied when working with people presenting with a range of 
physical and mental health problems, including stress, depression, anxiety, smoking, , 
pain, cancer, eating disorders, epilepsy, diabetes, tinnitus, trichotillomania, OCD and 
substance use (Association for Contextual Behavioural Science, 2015). Research 
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has also begun to emerge evaluating ACT for people with severe and enduring 
mental health problems. 
When working with people with severe and enduring mental health problems, 
it has been argued that attempting to reduce or modify private events may increase 
an already excessive inward focus; and that targeting symptoms directly may 
produce paradoxical effects (Pankey & Hayes, 2003). ACT instead aims to alter the 
‘believability’ or behavioural impact of problematic cognitions; in essence the 
person’s relationship with a private event rather than the private event per se (Bach & 
Hayes, 2002). As the symptoms of people with severe and enduring mental health 
problems are likely to persist, ACT seems well suited for this client group and could 
enable individuals to live more value-driven lives, even if unpleasant private events 
continue at some frequency (Pankey & Hayes, 2003). 
2.4 Published reviews of Acceptance and Commitment Therapy 
Several systematic reviews and meta-analyses have attempted to evaluate 
the effectiveness of ACT interventions. These have focussed on ACT for broad 
categories of physical disorders (Ost, 2014; Veehof, Oskam, Schreurs & Bohlmeijer, 
2011) or mental health problems (Bluett, Homan, Morrison et al., 2014; Hacker, 
Stone & MacBeth, 2015; Ost, 2014; Swain, Hancock, Hainsworth & Bowman, 2013), 
as well as work stress (Ost, 2014) and substance use (Lee, An, Levin & Twohig, 
2015). Regarding mental health problems, reviews have focussed either specifically 
on anxiety (Swain et al., 2013), anxiety and Obsessive Compulsive Disorder (OCD; 
Bluett et al., 2014), anxiety and depression (A-Tjak, Davis, Morina et al., 2015; 
Hacker et al., 2015) or more generally on ‘any’ mental health presentation (A-Tjak et 
al., 2015; Ost, 2014). 
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These reviews have found significant small to medium effect sizes for ACT in 
comparison to control conditions. For a small effect size (d=0.2), there is a 56% 
chance that a person picked at random from the treatment group will have an 
improved outcome compared to a person picked at random from the control group, 
whereas for a medium effect size (d=0.5) this probability of superiority is 64% 
(Magnusson, 2017). Hedges’ g effect size corrects for the slight overestimation of 
Cohen’s d (Borenstein et al., 2009) but can be interpreted using the same rule of 
thumb (i.e. for a small, medium and large effect size). 
In the largest meta-analysis for ACT to date, Ost (2014) reported an overall 
effect size of g=0.42 (p<.001) when combining 60 RCT’s (N=4234) evaluating ACT 
for people with somatic disorders, psychiatric disorders and work stress; however 
such a broad focus may have masked subgroup differences. Similar effect sizes 
have been reported in smaller meta-analyses evaluating ACT for substance use 
(g=0.43, p<.001; Lee et al., 2015), mental and somatic disorders (g=0.57, p<.001; A-
Tjak et al., 2015) and anxiety and OCD spectrum diagnoses (g=0.40, p=.16; Bluett et 
al., 2014). 
There are however differences in reported effect sizes between presenting 
problems, for example Ost (2014) reported that the type of disorder significantly 
mediated the overall effect size (p=.04), with the effect size higher for work stress 
(g=0.45) and somatic disorders (g=0.43) compared to mental health problems 
(g=0.27). Although the number of studies within specific mental health problem 
categories was too small for meta-analysis, Ost (2014) summarised the data for 
specific mental health presentations and attempted to categorise the efficacy of ACT 
for each in line with APA criteria for evidence-based treatments (i.e. well-established 
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treatment, probably efficacious, possibly efficacious or experimental). Differences 
were observed across presenting problems, with ACT identified as ‘probably 
efficacious’ for only generalised anxiety disorder, ‘possibly efficacious’ for depression, 
social anxiety disorder and psychotic symptoms, and experimental for borderline 
personality disorder (Ost, 2014).  
2.5 Limitations of previous reviews 
The reviews to date have captured a broad range of both mental health and 
physical health problems to varying degrees of severity, making it difficult to evaluate 
ACT for a specific, more circumscribed presenting problem. When a specific problem 
has been targeted, variation in the sample of studies has made it difficult to establish 
whether the results are representative of a particular population. For example, in an 
evaluation of ACT for depression (Hacker, Stone & MacBeth, 2015), samples 
included university students with low self-esteem, older adults with chronic pain and 
individuals with treatment resistant mental health problems within a specialist 
personality disorder clinic. When both the presenting problem and the population are 
narrowed the number of trials is reduced; for example, Lee et al., (2015) focussed on 
treatment seeking people with substance use problems and found only 10 RCT’s. It 
could be argued however that these results are more representative of the population 
of interest. Finally, individual trials and reviews tend to evaluate the effectiveness of 
ACT based on an improvement in symptoms. As discussed above, symptom 
reduction is not the primary target for an ACT intervention and perhaps process of 
change data (e.g. changes in psychological flexibility) should be given a greater 




2.6 Aim of the current review 
To date no review has evaluated whether Acceptance and Commitment 
Therapy can improve outcomes for people with severe and enduring mental health 
problems. The current review aims to fill this gap, whilst also attempting to address 
some of the limitations of previous reviews. For example, the present review focuses 
on a specific presenting problem (severe and enduing mental health problems, 
defined as psychotic disorders, bipolar affective disorder and major depressive 
disorders), therefore increasing the reliability of the findings for this particular 
population. Process of change measures relating to the targets of an ACT 
intervention, such as measures of psychological flexibility, will be considered in 
addition to symptom reduction data in an attempt to better understand study findings. 
Rehospitalisation outcomes will also be considered as a more objective outcome 
measure alongside participant rating scales; particularly as this client group has an 














3.1 Search strategy 
Empirical studies that evaluated the effectiveness of an ACT intervention for 
people with severe and enduring mental health problems were identified through a 
search of three electronic databases; PsychInfo, MedLine and Web of Science. A 
keyword search strategy was used for two topic areas (ACT and severe and enduring 
mental health problems) which were then combined. Search terms are presented in 
Table 1.  
It was anticipated that the ACT search terms would not identify compound 
therapies (i.e. therapies with an active component of ACT but in conjunction with 
other therapeutic systems), that are often given alternative intervention names. 











Table 1. Database search terms 
Search  Topic Keywords 




acceptance and commitment 
ACT 








SEVERE near2 MENTAL 
ENDURING near2 MENTAL 
MAJOR near2 MENTAL 
 
The initial database search was completed during April 2016. Search alerts 
were created for the databases to highlight any new publications that satisfied the 
search criteria between April 2016 and December 2016.  Following the electronic 
database search, the reference lists of suitable articles were screened to identify 
additional papers. The Association for Contextual Behavioural Science (2015) 
website produces a list of ACT publications and this was also consulted. The authors 
of papers identified through the database search were approached via Email to 
identify any potential publications that were under review or in press.  
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3.2 Inclusion and exclusion criteria 
In addition to peer-reviewed studies, ‘grey literature’ (e.g. unpublished doctoral 
theses) was included to reduce the impact of publication bias (Higgins & Green, 
2011). Randomised controlled trials (RCT’s) are considered to be the most rigorous 
study design (NICE, 2012), whilst non-randomised trials introduce a risk of bias 
(Higgins & Green, 2011). For this reason, only RCT’s that allocated participants to an 
ACT intervention plus at least one additional treatment arm were eligible for inclusion 
in the meta-analysis. Additional inclusion criteria were that the study was 1) 
published in English language and 2) recruited participants with a diagnosed severe 
and enduring mental health problem (defined as a psychotic or schizophrenia related 
disorder, bipolar disorder or major depressive disorder).  
Studies were excluded from the meta-analysis if only qualitative results were 
reported, if they replicated data previously published and included, or if the paper 
was unable to be retrieved through internet and library searches and attempts to 
contact the author. Where overlap of reported data were identified between peer-
reviewed journal articles and unpublished theses, the thesis was excluded.  
3.3 Study Selection 
Figure 1 presents the process of identifying articles for the review. The 
electronic database search identified 220 articles once duplicates (n=65) were 
removed. Three additional articles were identified through email correspondence with 
authors and each of these was screened for eligibility. No additional articles were 
identified through inspection of reference lists or through the Association for 
Contextual Behavioural Science website.  
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Of the 223 records screened, 175 were excluded due to either the topic area 
being not relevant (n=83) or the article being a non-intervention paper (n=92; i.e. 
book chapter, review paper, treatment manual). Forty-eight intervention papers were 
assessed using the inclusion and exclusion criteria and a further 35 papers were 
excluded for the reasons presented in Figure 1. Thirteen papers satisfied the criteria 
for the meta-analysis and were included. Twelve of these were original papers, whilst 
one reported a follow-up of a sample previously reported. Twelve articles were 
published within a peer-reviewed journal, whilst one was a thesis identified through a 
dissertation publication website. The study characteristics of the included papers are 






































285 records identified through 
database search 
3 additional records identified 
through other sources 
 
65 duplicates removed 
223 records screened using title 
and abstract 
175 records excluded 
Topic area not relevant (n=83)  
Non-intervention paper (n=92) 
48 full-text articles assessed for 
eligibility 
35 full-text articles excluded 
Sample not SMI (n=14) 
Not an RCT (n=11) 
Not published in English (n=3) 
Thesis paper for included peer 
reviewed article (n=2) 
Unable to access full text (n=2) 
Qualitative article (n=1) 
Re-analysis of data (n=2) 
 
13 articles included in the 
systematic review 
Original papers (n=12) 
Follow up of included sample (n=1) 
Figure 1. Identification of articles for review 
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Table 2. Study characteristics 
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I = intervention group, C = control group 
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TAU = Treatment as usual 
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3.4 Data extraction and coding 
Studies were coded for outcomes by the review author. Outcome measures 
were assigned to one of four outcome categories in line with the aims of the review; 
1) mental health (psychotic symptoms), 2) mental health (depression), 3) ACT 
related outcomes and 4) rehospitalisation. The outcome measures extracted from 
each study are presented in Table 3. 
End-of-intervention data (means, standard deviations and sample sizes for 
intervention and control groups) were favoured over change data. Where change 
data were reported, the author was contacted for end-of-intervention data and the 
latter was included where available. Intention-to-treat data are considered the least 
biased way to estimate intervention effects (Higgins & Green, 2011) and so this was 
favoured over completer-data when both were reported. Non-parametric data were 
not included in the analysis as violating parametric assumptions may lead to biased 
estimates and inappropriate standard errors (Van den Noortgate & Ongnena, 2005). 
Where multiple outcome measures of the same domain of functioning were 
reported within an outcome category, a decision was made to either select the more 
reliable outcome measure or to aggregate the effect sizes (Borenstein, Hedges, 
Higgins & Rothstein, 2009) to produce one effect size per outcome category. 
Validated measures were selected over more subjective participant self-ratings, with 
participant self-ratings utilised only if no validated measure of a construct was 
employed. Complete measures were favoured over subscales of incomplete 
measures as a more reliable measure of the complete construct (i.e. psychotic 
symptoms). Where all subscales of a measure were reported with no total score, the 
subscales were aggregated. Where two validated measures of the same construct 
were reported, the effect size was aggregated to produce a single effect size using 
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the correlation between measures as reported in the literature. Where no correlation 
was available within the literature, effect sizes were calculated using three 
correlation coefficients (0.3, 0.5 and 0.7) and if no difference in the effect size was 
observed this effect size was utilised. All outcomes within each category that were 
not selected are included in Appendix 1 and correlation coefficients between 
aggregated outcomes in Appendix 2. If two measures were reported within an 
outcome category that were not considered to measure the same construct (e.g. an 
acceptance measure and a mindfulness measure within the ACT outcome category), 















Table 3. Extracted outcome data 
Study 












Aggregated effect size of self-
ratings of psychotic symptoms 
(frequency, believability, and 
distress) 
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(2011) 
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Brief Psychiatric Rating Scale; 
2
Hamilton Rating Scale; 
3
Beck Depression Inventory; 
4
Acceptance 
and Action Questionnaire; 
5
Positive and Negative Syndrome Scale; 
6
Hospital Anxiety and Depression 
Scale; 
7
Voices Acceptance and Action Questionnaire; 
8
Montgomery Asberg Depression Rating Scale; 
11
Automatic Thoughts Questionnaire; 
9
Quick Inventory of Depressive Symptomology-Clinician; 
10





3.5 Quality assessment 
The quality of each study was assessed using Down’s and Black’s (1998) 
Quality Index (see Appendix 3). The Quality Index assesses important features of 
both internal and external validity as well as reporting standards and power 
calculations. Each of the 27 items was scored as either present or absent, yielding a 
Quality Index score for each study between 0 and 27.  
A subsample of studies was selected at random and these were scored by a 
second rater to assess reliability of the ratings. Interrater reliability analysis was 
conducted by calculating the Kappa statistic. Kappa ranges from -1 to +1; with 1 
indicating perfect agreement between raters (McHugh, 2012). Reliability of the 
quality assessment was good (Kappa = 0.81), and would be considered to be within 
the category of ‘almost perfect agreement’ (McHugh, 2012). Discrepancies were 
resolved through discussion between the raters. The quality assessment of each 





Table 4. Quality Index assessment 


















1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 
Bach & Hayes 
(2002)   
                                                    17 
Gaudiano & 
Herbert (2006)   
                                                    21 
Petersen & Zettle 
(2009)   
                                                    19 
White et al (2011) 
   
                                                    22 
Folke et al (2012) 
   
                                                    19 
Shawyer et al 
(2012)   
                                                    22 
Broten (2013) 
 
                                                      20 
Gaudiano et al 
(2015)                                                       
20 
Tyrberg et al., 
(2016) 
                         
  
20 
Shawyer et al 
(2016)                                                       
23 
Boden (2016) 
                                                       
16 
Gumley et al., 
(2016)                            
21 
1
Reporting: Items 1 to 10; 
2
External Validity: Items 11 to 13; 
3
Internal Validity (bias): Items 14 to 20; 
4








3.6 Quality review 
The overall score for the studies ranged from 16 to 22 (out of 27). Studies 
generally provided good descriptions of study aims, measurement (using reliable and 
valid measures), interventions and results.  Samples were generally well described, 
were recruited from and received interventions where they would routinely receive 
treatment and were recruited from the same population across treatment arms (i.e. 
both the intervention group and the control group were recruited from the same 
hospital).  
Although studies often reported the number of participants lost to follow-up 
there was rarely a description of those lost or a comparison of completers and non-
completers. Furthermore, studies reported the number of participants who agreed to 
participate and often the number of refusers; however there was a limited number of 
comparisons between those who consented and those who refused, or a comparison 
of consenters with the population for the sample. Bach and Hayes (2002) compared 
consenters with the sample population and identified that consenters were less likely 
to have a secondary substance abuse diagnosis and were more likely to have had a 
previous hospital admission. Only one study (Gaudiano & Herbert, 2006) reported no 
significant differences between consenters and refusers across demographic 
variables. Each of these limitations raises questions about the representativeness of 
the samples. 
Only two studies (Shawyer et al., 2012; Shawyer et al., 2016) reported a 
power analysis calculation and one of these (Shawyer et al., 2012) was 
underpowered. The presence or absence of any adverse events was also often 
omitted from reports. In terms of blinding, it is often not possible to blind participants 
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in psychological intervention studies to their treatment condition, which resulted in 
studies losing quality points. Blind assessment of outcome measures occurred in 
only six of the 12 studies, raising questions about possible assessment bias. 
3.7 Data analysis 
A separate meta-analysis was conducted for each outcome (psychotic 
symptoms, depression, ACT related outcomes and rehospitalisation) using the “Meta” 
package from the R programme (R Core Team, 2015; Schwarzer, 2007; Schwarzer, 
Carpenter & Rucker, 2015). As studies often reported both post-intervention and 
follow-up outcomes, separate analyses were conducted for both categories to identify 
any differences in effect over time. Summary effect sizes using standardised mean 
differences and 95% confidence intervals (CI) were calculated for each outcome 
category that used continuous outcomes (psychotic symptoms, depression and ACT 
outcomes). The standardised mean difference transforms all effect sizes to a 
common metric, and therefore allows the inclusion, within the same analysis, of 
similar outcomes that were measured using a range of different scales (Borenstein et 
al., 2009). As Cohen’s d has been shown to slightly overestimate the true effect, 
particularly in small samples, all calculations were undertaken on the Hedges’ g 
transformed standardised mean difference score, which contains a correction for this 
slight overestimation (Borenstein et al., 2009). However, Hedges’ g was back-
transformed to the more familiar Cohen’s d for presentation in summary tables and 
forest plots. The summary effects were interpreted using Cohen’s rule of thumb for a 
small (0.2), medium (0.5) and large (0.8) effect (Cohen, 1988). For outcomes that 
used frequency data (i.e. rehospitalisation rate), the relative risk ratio was calculated. 
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A fixed-effects model assumes that the individual trial perfectly measures (i.e., 
without error) the outcome of interest and the only source of between group 
heterogeneity is sampling variation. This assumption is, quite obviously, 
inappropriate for the evaluation of psychological constructs which are often 
measured with considerable error and may be moderated by methodologically 
uncontrolled factors. In contrast, the random effects model accommodates such 
methodological and measurement error. In the current review, it was assumed that 
the studies were not functionally identical and varied in terms of the quality of 
outcome measurement, the way that  treatment was implemented, trial methodology 
and population characteristics (among other features). Accordingly, in line with 
recommendations (Hak, Van Rhee & Suurmond, 2016), the random-effects model 
was employed in the meta-analysis of all outcomes, even when significant 
heterogeneity was not identified. 
Sensitivity analyses were conducted in order to test the validity and 
robustness of the results.  Firstly, the quality effects model was reported in addition to 
the random effects model. The quality effects model is a measure of attenuation of 
effect due to methodological variation and is equivalent to the effect size that may be 
obtained if all of the studies were of the same methodological standard as the best 
study in the group. Secondly, the impact of any individual influential study was 
assessed using a “one left out” procedure, where each study was omitted from the 
meta-analysis in turn (Dias, Sutton, Welton & Ades, 2011). If the results of the meta-
analysis with a study omitted are consistent with the overall results of the meta-
analysis then there is confidence that the overall meta-analysis is robust to the over-
influence of individual studies.  
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Heterogeneity in the study effects was quantified using Higgins’ I2. This 
statistic indicates the proportion of heterogeneity reflecting real variation in true effect 
size relative to within-study error. Value ranges of 0-50%, 50-75% and 75-100% have 
been suggested to signify low, medium and high levels of heterogeneity respectively 
(Higgins, Thompson, Deeks & Altman, 2003). As all of the studies within the current 
review were randomised controlled trials, a more rigorous research design is implied 
and therefore a lower level of heterogeneity due to methodological variation was 
expected. With this is mind, a more stringent acceptability level of Higgins I2 (0-50%) 
was utilised.  
Publication bias was identified using a combination of Egger’s statistic (Egger, 
Smith, Schneider & Minder, 1997) and examination of funnel plots. If publication bias 
was suggested then a trim and fill procedure (Duval & Tweedie 2000a; Duval & 
Tweedie, 2000b) was used to estimate attenuation of the meta-analytic effect and the 
fail-safe number was calculated (Borenstein et al., 2009). Trim and fill uses an 
iterative procedure to remove the most extreme small studies from the positive side 
of the funnel plot and add studies to the area associated with publication bias. The 
effect size is recomputed at each iteration until the funnel plot is symmetric about the 
attenuated effect size. The effect attenuated for publication bias can then be 







4.1 Participant characteristics 
 The total sample size across the 12 trials was 470, with a range across studies 
from 18 to 96 participants. The proportion of males and females varied greatly across 
studies. Participants were typically aged in their thirties or forties and were recruited 
primarily from inpatient or mixed (inpatient and community) samples. Where ethnicity 
was reported, the participants were predominantly Caucasian, except for one study in 
which participants were predominantly African-American (Gaudiano & Hebert, 2006). 
Approximately half of the studies (n=6) recruited participants from the USA, with 
other studies recruiting from either Australia (n=2), Sweden (n=2) or the UK (n=2). 
Eight studies recruited participants with a psychotic disorder, two with a major 
depressive disorder and two with a combination of diagnoses (either major 
depression and bipolar affective disorder, or schizophrenia and major depressive 
disorder). 
4.2 Intervention characteristics  
Number of intervention sessions varied across studies from two sessions 
(Tyrberg et al., 2016) to 15 sessions in addition to two follow-up sessions (Shawyer 
et al., 2012). The majority of studies (n=11) delivered one-to-one intervention 
sessions with only one study evaluating group therapy (Folke et al., 2012). Ten 
studies compared the ACT intervention to treatment as usual and two studies 
compared ACT to an active intervention (befriending).  
4.3 Meta-analysis 
Results of the meta-analysis are presented for each of the four outcome 
categories in turn; psychotic symptoms, depression, ACT related outcomes and 
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rehospitalisation rate. Within the first three outcome categories, post-intervention 
outcomes are presented first followed by follow-up outcomes. For the fourth outcome 
(rehospitalisation rate), only follow-up data are presented. 
4.3.1 Psychotic symptoms 
 Seven studies (n=317) reported outcomes related to psychotic symptoms. Five 
of these (n=210) reported post-intervention outcomes and six (n=299) reported 
follow-up outcomes. The mean length of follow up was 4.3 months (range 3 to 6 
months).  
Post-intervention results 
Figure 2 displays the forest plot with the effect size and 95% confidence 
interval (CI) for each individual study and the omnibus test of the combined effect. 
Two studies favoured the intervention, whilst three studies favoured the control group. 
Confidence intervals for all studies included zero, indicating that no individual study 
showed a significant effect.  
 
 
Figure 2. Forest plot for psychotic symptoms post-intervention 
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The random effects model revealed a no significant difference between 
treatment and control groups at the post-intervention time point (SMD=-0.02, 95% CI 
[-0.30-0.26], p=0.91).  Weighting studies by their quality in the quality effects model 
did not influence the effect (WMD=-0.04, 95% CI [-0.39-0.31], p=0.82). The results 
remained non-significant when the “one left out” procedure was applied. 
Heterogeneity within the sample was low (I2=1.73%).  
Regarding publication bias, Egger’s statistic showed no significant bias 
(p=0.91). This was confirmed using trim and fill procedures where the corrected 
estimate (SMD=-0.02, 95% CI [-0.30-0.26], p=0.91) remained the same as the 
uncorrected estimate. The failsafe number was unattainable as no significant effect 
was observed. 
Follow-up results 
The forest plot at follow-up (Figure 3) shows that three studies favoured the 
intervention, whilst two studies favoured the control group. Four studies showed no 
significant effect, whilst one study showed a significant effect in favour of the 
intervention.  
 
Figure 3. Forest plot for psychotic symptoms at follow-up 
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The random effects model showed no significant difference between treatment 
and control groups at the post-intervention time point (SMD=0.16, 95% CI [-0.14-
0.45], p=0.30).  Weighting studies by their quality in the quality effects model slightly 
reduced the effect (WMD=0.06, 95% CI [-0.30-0.42], p=0.75). The results remained 
non-significant when the “one left out” procedure was applied. Heterogeneity within 
the sample was low (I2=16.8%).   
Egger’s statistic showed no significant bias (p=0.60). This was confirmed 
using trim and fill procedures where the corrected estimate (SMD=0.19, 95% CI [-
0.09-0.47]) showed trivial correction to the uncorrected estimate (SMD=0.16, 95% CI 
[-0.14-0.45]). The failsafe number was not calculated as no significant effect was 
observed. 
4.3.2 Depression outcomes 
 Seven studies (n=190) reported depression outcomes. Six of these (n=161) 
reported post-intervention outcomes and five (n=143) reported follow-up outcomes. 
The mean length of follow up was 7.4 months (range 3 to 18 months).  
Post-intervention results 
Figure 4 displays the forest plot with the effect size and 95% CI interval for 
each individual study and the omnibus meta-analytic result. Five studies favoured the 
intervention, whilst one study favoured the control group. Confidence intervals for all 





Figure 4. Forest plot for depression outcomes post-intervention 
 
The random effects model revealed a significant difference between treatment 
and control groups at the post-intervention time point (SMD=0.39, 95% CI [0.07-0.71], 
p=0.02).  Weighting studies by their quality in the quality effects model showed trivial 
correction to the model (WMD=0.44, 95% CI [0.09-0.79], p=0.01). Using the “one left 
out” procedure, the effect was no longer significant when the study by Folke et al., 
(2012) was omitted (SMD=0.31, 95% CI [-0.05-0.67], p=0.09) or when the study by 
Gumley et al., (2016) was omitted (SMD=0.32, 95% CI [-0.03-0.68], p=0.07). This 
suggests that the conclusion is sensitively dependent upon the inclusion of these two 
studies. Heterogeneity within the sample was low (I2=0.0%).   
Egger’s statistic showed no significant publication bias (p=0.58). The funnel 
plots (Figure 5) suggest that a study with a relatively low effect size is missing. Using 
the trim and fill method the corrected estimate (SMD=0.36, 95% CI [0.05-0.67]) 
showed trivial correction to the uncorrected estimate (SMD=0.39, 95% CI [0.07-0.71]).  
Using the Rosenthal (1979) algorithm, 14 (233%) unpublished null studies are 
required to reduce the six observed meta-analytic effect to non-significance. As the 
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failsafe number is twice that of the included it would be safe to assume that this 
conclusion should be robust to effects of unpublished null studies. 
 
Figure 5. Funnel Plots for depression outcomes post-intervention 
 
Follow-up results 
Figure 6 displays the forest plot with the effect size and 95% Cl for each 
individual study and the combined meta-analytic result. All five studies favoured the 
intervention, however no significant effect was observed for an individual study. 
 
Figure 6. Forest plot for depression outcomes at follow-up 
 
Uncorrected Funnel Plot Corrected Funnel Plot 
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The random effects model revealed a significant difference between treatment 
and control groups at the post-intervention time point (SMD=0.43, 95% CI [0.08-0.78], 
p=0.02).  Weighting studies by their quality in the quality effects model showed trivial 
correction to the model (WMD=0.48, 95% CI [0.08-0.87], p=0.02). The effect did not 
remain significant when the study by White et al., (2011) was omitted (SMD=0.38, 
95% CI [-0.01-0.77], p=0.06). Heterogeneity within the sample was low (I2=0.0%).  
Egger’s statistic showed no significant publication bias (p=0.37). The funnel 
plots (Figure 7) suggest that a study with a relatively low effect size is missing. Using 
the trim and fill method the corrected estimate (SMD=0.41, 95% CI [0.07-0.75]) 
showed trivial correction to the uncorrected estimate (SMD=0.43, 95% CI [0.08-0.78]). 
Using the Rosenthal (1979) algorithm, 10 (200%) unpublished null studies are 
required to reduce the five observed meta-analytic effect to non-significance. Again, it 
would be safe to assume that this conclusion should be robust to effects of 
unpublished null studies. 
 
Figure 7. Funnel Plots for depression outcomes at follow-up 
 
 
Uncorrected Funnel Plot Corrected Funnel Plot 
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4.3.3 ACT specific outcomes 
 Eight studies (n=294) reported ACT related outcomes. Seven of these (n=267) 
reported post-intervention outcomes and five (n=208) reported follow-up outcomes. 
The mean length of follow up was 6.8 months (range 3 to 10 months). Data from one 
additional study (n=21) were not included as non-parametric data were reported. 
Post-intervention results 
Figure 8 displays the forest plot with the effect size and 95% CI for each 
individual study and the omnibus meta-analytic result. Five studies favoured the 
intervention, whilst two studies favoured the control group. Two studies 
independently indicated a significant effect in favour of the intervention (Petersen & 
Zettle, 2009; Gumley et al., 2016). 
 
Figure 8. Forest plot for ACT outcomes post-intervention 
 
The random effects model showed a significant difference between treatment 
and control groups at the post-intervention time point (SMD=0.33, 95% CI [0.01-0.65], 
p=0.04).  Weighting studies by their quality in the quality effects model showed trivial 
correction to the model (WMD=0.36, 95% CI [0.02-0.70], p=0.04). Heterogeneity 
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within the sample was low (I2=30.9%). Using the “one left out” procedure”, the results 
were no longer significant when one of four studies were omitted; Gaudiano et al., 
(2015; p=0.09), Petersen and Zettle (2009, p=0.07), Shawyer et al., (2016, p=0.11) 
and Gumley et al., (2016, p=0.13). 
Egger’s statistic showed no significant bias (p=0.75). This was confirmed 
using trim and fill procedures where no missing studies were identified using funnel 
plots and the corrected estimate (SMD=0.33, 95% CI [0.01-0.65]) remained the same 
as the uncorrected estimate. Using the Rosenthal (1979) algorithm, 3 (43%) 
unpublished null studies are required to reduce the four observed meta-analytic 
effect to non-significance. This suggests that this result is not robust to publication 
bias and may lose significance with the publication of only a few null studies. 
Follow-up results 
Figure 9 displays the forest plot with the effect size and 95% CI for each 
individual study and the omnibus meta-analytic result. Four studies favoured the 
intervention whilst one favoured the control group. No study independently showed a 
significant effect. 
 
 Figure 9. Forest plot for ACT outcomes at follow-up 
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The random effects model revealed no significant difference between 
treatment and control groups (SMD=0.13, 95% CI [-0.15-0.41], p=0.36).  Weighting 
studies by their quality in the quality effects model showed trivial correction to the 
model (WMD=0.14, 95% CI [-0.19-0.46], p=0.41). Heterogeneity within the sample 
was low (I2=0.0%). The results remained non-significant when the “one left out” 
procedure was applied. 
Egger’s statistic showed no significant publication bias (p=0.91). Trim and fill 
procedures indicated that one study with relatively low effect size was missing. The 
corrected model (SMD=0.11, 95% CI [-0.16-0.37]) showed trivial correction to the 
uncorrected model. The failsafe number was not calculated as no significant effect 
was observed. 
4.3.4 Rehospitalisation 
Four studies (n=180) reported rehospitalisation rates. The mean length of 
follow up was 4.5 months (range 4 to 6 months). Figure 10 displays the forest plot 
with the relative risk and 95% CI for each individual study and the omnibus meta-
analytic result. Three studies favoured the intervention, whilst one study favoured the 





Figure 10. Forest plot for rehospitalisation rate 
 
The random effects model revealed no significant difference between 
treatment and control groups (RR=-0.36, 95% CI [-0.94-0.22], p=0.22).  Weighting 
studies by their quality in the quality effects model showed trivial correction to the 
model (RR=-0.43, 95% CI [-1.09-0.22], p=0.19). Heterogeneity within the sample was 













5.1 Summary of findings 
The current review aimed to evaluate whether Acceptance and Commitment 
Therapy (ACT) improves outcomes for people with severe and enduring mental 
health problems. Reviews to date have focused on whether ACT is an effective 
intervention for mental health problems more generally, combining both clinical and 
sub-clinical presentations across a wide range demographics and treatment settings 
(e.g. schools, prisons, physical health settings). In contrast to previous reviews, a 
strength of the current review is that it focused on a specific clinical population (those 
with severe and enduing mental health problems), making the results more reliable 
for this particular population. Furthermore, while previous reviews primarily reported 
outcomes related to mental health symptoms, the current review also examined 
outcomes specifically related to ACT processes as well as the more objective 
outcome of rehospitalisation. 
 Twelve quantitative studies met the inclusion criteria and were included in the 
meta-analysis. Seven of the 12 studies measured psychotic symptoms, using either 
the Positive and Negative Syndrome Scale (PANSS), the Brief Psychiatric Rating 
Scale (BPRS) or self-ratings of psychotic symptoms (frequency, believability, and 
distress). The results suggest that ACT did not improve psychotic symptoms 
compared to the control group either at post-intervention or follow-up time points. 
Tests of sensitivity, heterogeneity and publication bias indicated that this result was 
robust to publication bias and the publication of null studies in the future.  
 Regarding depressive symptoms, seven of the 12 studies reported outcomes, 
using a range of six different outcome measures. The Beck Depression Inventory 
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was the most consistent measure of depression, employed across three of the 
studies. The results suggested that those who received ACT exhibited fewer 
symptoms of depression after the intervention than those who received the control 
condition; and this improvement was maintained at follow-up. At both time points, a 
large number of null studies would be required to reduce the effect to non-
significance, although sensitivity analyses suggested that the results were potentially 
being influenced by individual studies. The effect size reported here for depression 
outcomes (0.42) was larger than the effect size reported for mood outcomes in 
similar samples that received CBT; an effect size of d=0.29 in people with a 
diagnosis of bipolar disorder (Gregory, 2010) and of d=0.36 in people with a 
diagnosis of psychosis (Wykes, Steel, Everitt & Tarrier, 2008). 
 The analysis for ACT specific outcomes focused on psychological flexibility 
measured primarily by the Acceptance and Action Questionnaire (AAQ; 7 studies) 
with one study using the Voices Acceptance and Action Questionnaire (VAAS). The 
results suggested that the intervention significantly increased psychological flexibility 
compared to the control group post-intervention, however this was not maintained at 
follow-up. The robustness of the result is questionable, with a relatively small amount 
of null results required to reduce the significant post-intervention result to non-
significance, and sensitivity analyses suggesting that this result was potentially being 
driven by individual studies.  
 ACT did not significantly reduce the risk of rehospitalisation compared to 
controls. Only four studies measured rehospitalisation; three of these showed that 
ACT reduced the risk of rehospitalisation compared to controls, whereas one showed 
the opposite.  
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5.2 Potential mediators of effect size 
 Examining the impact of study level co-variates on the effect sizes using 
meta-regression was not possible within the current review due to the small number 
of studies in each analysis. For this procedure, the ratio of studies to covariates 
needs to be large, with a recommendation of 10 studies per co-variate as a minimum 
(Borenstein et al., 2009). Heterogeneity (assessed using Higgin’s I2) was low across 
the analyses, which may be a result of the analyses focusing on a specific 
intervention for a specific client group and conducting a separate meta-analysis for 
each outcome category. Furthermore, the potential influence of studies based on 
their methodological quality was controlled for by including the quality effects model. 
However two important factors were not considered independently within the 
analyses. First, the within-study approach to statistical analysis (i.e. the use of 
intention-to-treat versus completer-data), and second, the type of control group used 
(i.e. active treatment control versus ‘treatment as usual’). 
 Several meta-analyses have compared effect sizes between studies that 
reported completer-data and those that reported intention-to-treat data. Hans and 
Hiller (2013) reported a significantly larger effect size when completer-data were 
reported compared to intention-to-treat data; a trend that has also been observed by 
others (A-Tjak et al., 2016; Johnsen & Friborg, 2015). Within the current review, five 
studies reported intention-to-treat data (Folke et al., 2012; Gaudiano & Herbert, 2006; 
Gaudiano et al., 2015; Gumley et al., 2016; Shawyer et al., 2016), whilst the 
remaining studies reported completer-data. Although not statistically analysed, visual 
inspection of the forest plots does not appear to indicate a bias whereby completer-
data produces larger effect sizes. In fact, in the analysis for depression outcomes at 
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post-intervention, the three studies with the larger effect sizes are all based on 
intention-to-treat analyses. This would suggest that the results of the current review 
are not being driven by larger effect sizes generated using completer-data, thereby 
increasing the validity of the findings. 
The second area was associated with the control group used as a comparison 
to the ACT intervention. Previous meta-analyses have suggested that larger effect 
sizes are observed when ACT is compared to ‘treatment as usual’ than other active 
comparison groups (e.g. A-Tjak et al., 2015; Ost, 2014). Within the current review two 
studies used an active, manualised treatment as the comparison condition 
(‘befriending’; Shawyer et al., 2012; Shawyer et al., 2016), whilst the remaining 
studies compared ACT to treatment as usual. Again, no statistical comparison of 
studies based on control group was undertaken due to the small number of studies; 
however visual inspection of the forest plot does not suggest that those studies with 
active treatment comparisons produced smaller effect sizes in relation to the 
remaining studies. 
5.3 Fidelity to the key ingredients of the ACT intervention 
 It is surprising that, as increasing psychological flexibility is the primary target 
of ACT, the results for the process outcome were not more robust and maintained 
over time. This leads to two important questions; (1) how is ACT delivered in the trials, 
and (2) are ACT outcomes measured in a reliable and valid way. 
 Fidelity assessments are often used to measure adherence to the treatment 
manual or protocol. Within the current review six studies reported a fidelity 
assessment and where results were reported fidelity ratings were high. Within the 
ACT outcome analysis, at both time points (post-intervention and follow-up), 
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outcomes in favour of the ACT intervention were observed for studies that reported 
fidelity assessments, and outcomes in favour of the control group were observed for 
studies that reported no fidelity assessments. Although the suggestion can only be 
tentative at this point without further exploration and statistical analyses, it seems 
possible that studies with high levels of adherence to the ACT protocol or manual 
were more likely to result in increased psychological flexibility within the treatment 
condition. 
 ACT utilises a range of methods to promote psychological flexibility, including 
mindfulness, defusion and values-based living. The current analysis focused on a 
general measure of psychological flexibility (i.e. the AAQ) to evaluate ACT related 
outcomes; as this was consistently reported by the majority of studies. This is also a 
reliable and valid measure of the construct (Bond, Hayes, Baer et al., 2011). This 
meant, however, that additional outcomes of important ACT processes were not 
evaluated. Only three studies measured additional ACT processes, including 
mindfulness (Gumley et al., 2016; White et al., 2011) and values-based living 
(Tyrberg, et al., 2016). These studies showed that ACT significantly increased 
mindfulness (Gumley et al., 2016; White et al., 2011) but not values-based living 
(Tyrberg et al., 2016) compared to the control.  Although the number of studies 
measuring these constructs was too small to be subjected to meta-analysis, it is 
important to highlight this area.  
 When evaluating treatment approaches it is important to not only determine 
whether an intervention can improve broad outcomes, but to also consider which 
aspect or aspects of the intervention promote what predicted change to what specific 
outcomes. The evidence base for ACT for people with severe and enduring mental 
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health problems is still in its infancy, and it is difficult therefore to statistically explore 
the different concepts at this stage. Qualitative interviews with participants from a trial 
included in the meta-analysis (Shawyer et al., 2016) reinforce the importance of this; 
suggesting that the different components of ACT are received differently by 
individuals. For example, eight out of nine participants interviewed stated that 
mindfulness was helpful to them, whilst only two found the concept of acceptance 
beneficial (Bacon, Farhall & Fossey, 2014). 
5.4 Limitations of the research literature 
There are several limitations to the existing literature that make it difficult to 
draw firm conclusions from the present data. Although the number of trials evaluating 
ACT has been increasing in recent years, the evidence base evaluating ACT for 
people with severe and enduring mental health problems is still in its infancy, and it is 
difficult to generate reliable findings based on a small number of studies with a 
relatively small number of participants. More studies would allow for more robust 
meta-analytical conclusions. Available studies measure different outcomes; which 
reduces the number of studies within the meta-analysis further, and raises questions 
about the type of outcomes that trials should be reporting. When an outcome is 
consistently reported across studies, a range of different measures is used, again 
raising questions about which measure is the most reliable and valid measure of a 
particular construct for a particular client group. 
Ten of the 12 studies in the review compared ACT to ‘treatment as usual’, and 
as a result it is difficult to attribute effects to a specific intervention. It is possible that 
other non-specific intervention factors, such as increased contact time or the 
therapeutic alliance, were responsible for the observed intervention effects. One 
44 
 
study demonstrated statistical mediation of the intervention effect by changes on the 
Acceptance and Action Questionnaire (AAQ; Gumley et al., 2016); suggesting that 
within-study effects were attributable to the intervention components rather than the 
non-specific factors. Future research should consider using an active control group, 
such as CBT, and be able to demonstrate mechanisms of change (i.e changes in 
acceptance, mindfulness or values-based living, for example). This would allow for 
refinement of the intervention and consideration of which components of an 
intervention promote change.  
5.5 Convergence with other reviews 
 During the course of this review, a meta-analysis of four randomised 
controlled trials comparing ACT to treatment as usual for people with psychosis was 
published (Tonarelli, Pasillas, Alvarado et al., 2016). They reported that, based on 
two studies, ACT significantly improved negative symptoms of psychosis but had no 
effect on positive symptoms. They also reported that, based on two studies, those 
who received ACT had significantly lower risk of rehospitalisation compared to those 
who received ‘treatment as usual’. The results of the current review differ from the 
results of Tonarelli et al., (2016), with the current review reporting no effect on either 
psychotic symptoms or rehospitalisation rate. The primary limitation of the Tonarelli et 
al., (2016) review was the sample size. Only four studies were included in the review; 
and only two studies were included in each of the analyses. This number is very 
small and brings into question the reliability of the findings. The current review 
included each of the four studies selected for Tonarelli et al., (2016) review, with an 
additional eight studies included. This would suggest that the results and conclusions 
of the current review are more robust and reliable.  
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5.6 Clinical implications 
 The finding that ACT improves depression for this client group, and that this 
improvement is maintained over time, is an important one. The experience of 
psychosis is associated with increased risk of depression (Birchwood, Iqbal, 
Chadwicjk & Trower, 2000), and depression in this context has been identified as a 
major factor contributing to poorer quality of life (Meijer, Koeter, Sprangers & Schene, 
2009; Saarni et al., 2010) and increased levels of hopelessness and suicide (White, 
McCreery, Gumley & Mulholland, 2007). Reducing depression amongst this client 
group is therefore a primary target for psychological interventions, and the results of 
the current review, although tentative at this stage, suggest that ACT may be an 
appropriate intervention and is worthy of further study.  
 In terms of attempting to explain how ACT is an effective treatment for 
depression, it has been proposed that depression in the context of psychosis is 
associated with lower psychological flexibility (White, Gumley, McTaggart et al., 
2013), and therefore changes in psychological flexibility will in turn lead to changes in 
depression. Some studies have begun to explore the change mechanisms in this 
relationship. For example, Gumley et al., (2016) found a significant correlation 
between changes in BDI scores and changes in AAQ scores, suggesting that as 
flexibility increased, depression decreased. The same study reported the same 
significant correlation between BDI scores and KIMS (Kentucky Inventory of 
Mindfulness Skills; Baer, Smith & Allen, 2004) scores. Finally, Shawyer (2007) 
reported that greater psychological flexibility in relation to hallucinatory voices was 
associated with lower depression. 
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 The results of the current review found no change in psychotic symptoms 
following an ACT intervention; however, it is often highlighted that the target of ACT 
is not symptom reduction, but rather increase in psychological flexibility. It is 
recognised that this change in psychological flexibility may in turn reduce or improve 
symptoms over time. Follow-up lengths of studies in the review that measured 
psychotic symptoms were short (mean follow up of 4.3 months), and so it would be 
important for studies to assess psychotic symptoms longer term in order to 
understand whether or not changes in psychological flexibility correlate to changes in 
psychotic symptoms over time.  
5.7 Conclusion 
 The question of whether or not ACT is an effective treatment for people with 
severe and enduring mental health problems is a difficult one to answer with certainty 
at this current stage of evidence. The answer, in part, depends on what one 
perceives constitutes a successful intervention. If symptom reduction is the aim, then 
the current review suggests that ACT is useful in decreasing depressive symptoms, 
but not psychotic ones, amongst this client group. If the target of the intervention is to 
increase psychological flexibility, then the current review provides preliminary 
evidence that ACT can increase psychological flexibility in the short term for this 
client group, but that these changes are not maintained in the longer term. If the 
target of an intervention is to attempt to reduce reoccurrence of symptoms and keep 
people out of hospital, an important consideration for this group, then the results 
suggest that ACT is no more successful than treatment as usual. 
All of these treatment aims are important, and moving forward future research 
should consider each of them. Of particular importance is determining why 
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interventions work, not just if they do, and measurement of additional processes of 
change, rather than reliance solely on the AAQ, may help to do this. Mindfulness and 
values work are two core concepts to ACT and their role in the effectiveness of the 
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Chapter II: Empirical Paper 
  
An exploration of shame, psychological flexibility and the use of alcohol or drugs in 




































Introduction: Substance use is prevalent amongst people with severe and 
enduring mental health problems and is associated with negative outcomes and high 
levels of resource use. The role of shame in the development and maintenance of 
both substance use and mental health problems independently has been 
demonstrated; however research is yet to explore the role of shame in the 
relationship between mental health and substance use in this complex client group. 
Similarly, the role of psychological flexibility has been explored in both individual 
research fields but not in co-existing presentations. 
Method: A cross-sectional questionnaire study was used to explore the 
relationships between mental health, substance use, shame and psychological 
flexibility in people with severe mental health problems admitted to inpatient units.   
Planned analyses included correlational as well as exploratory mediation and 
moderation analyses. 
Results: Forty-nine participants consented to the study. Participants were 
typically male (73.5%), white British (53.1%) and had an average age of 39 years. 
Results showed a significant relationship between psychological distress and 
substance use. This relationship was fully mediated by shame. Psychological 
flexibility did not moderate the effect of shame on substance use. 
Conclusion: When working with this client group, targeting shame may be an 
important focus for psychological interventions. Acceptance and Commitment 
Therapy is presented as a therapeutic framework working with shame.  The role of 
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psychological flexibility in the relationship between psychological distress, shame and 






















Substance use, particularly alcohol and cannabis use, is highly prevalent 
amongst people with severe and enduring mental health problems (Graham, Copello, 
Griffith et al., 2016; NICE, 2011). Co-existing substance use and mental health 
problems are increasingly recognised problems that have been associated with 
poorer outcomes and high levels of resource use when compared to either problem 
on its own (Banjaree, Clancy & Crome, 2002; NICE, 2011). As a result, people with 
these co-occurring problems are often perceived as difficult to engage in treatment 
and as ‘lacking motivation to change’ (van Boekel, Brouwers, van Weeghel & 
Garretsen, 2013). This is compounded by intervention trials that show mixed results 
and are plagued with recruitment and retention difficulties (Barrowclough, Haddock, 
Wykes, Beardmore et al., 2010).  
The main focus to date has been on intervention techniques (mostly 
behavioural or motivational based) that may improve outcomes for individuals with 
co-existing mental health and substance use problems, with less attention being paid 
to potential core psychological factors that may underlie and be associated with the 
development and severity of these combined problems (Levin, Lillis, Seeley, Hayes 
et al., 2012). Two such factors that have been shown to be important in both 
conditions independently include the experience of shame and the presence and 
extent of psychological flexibility as an adaptive response. The lack of focus on 
underlying psychological factors as possible mechanisms of change may limit the 




2.2 The experience of shame  
Shame has been described as a powerful self-conscious emotion involving a 
global negative feeling about the self that can lead to a desire to hide or escape 
(Scheel, Bender, Tuschen-Caffier, Brodführer et al., 2014; Wiklander, Samuelsson, 
Jokinen, Nilsonne et al., 2012). Shame is elicited when one percieves their personal 
attributes or actions as unattractive or worthless, consequently leading to anticipation 
of rejection from others or loss of social status (Gilbert, 1998; Gilbert, 2000; Gilbert, 
2003). In some cases, shame can be adaptive as it can help to inhibit further threats 
to the self (Michail & Birchwood, 2013), however high levels of persistent shame are 
associated with a range of negative internalising and externalising symptoms or 
behaviours, including mental health problems and substance use. In light of this, 
there has been increasing interest in the relationship between the experience of 
shame and psychological difficulties (Dinis, Carvalho, Gouveia & Estanqueiro, 2015). 
Michail and Birchwood (2013) have argued that stigma acts as a catalyst for 
people who are vulnerable to experience shame, for example those who developed 
early maladaptive attachment styles or experienced dysfunctional parenting. 
Therefore, an important contributor to the experience of shame is the societal 
devaluation of stigmatized identities (Luoma & Platt, 2015). Strong, negative 
stigmatizing atttudes towards people with mental health problems and people who 
use substances are prevalent amongst both the general population and healthcare 
professionals (Barry, McGinty, Pescosolido & Goldman, 2014; Phillips & Shaw, 2013; 
Stuber, Rocha, Christian & Link, 2014; van Boekel et al., 2013). Both problems are 
more stigmatized than physical health problems (Ahmedani, Kubiak, Kessler, de 
Graaf et al., 2013; Corrigan, Lurie, Goldman, Slopen et al., 2005), and there is 
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evidence to suggest that substance use is more stigmatized than mental health 
(Barry et al., 2014; Corrigan et al., 2005;; van Boekel et al., 2013).  
Negative judgements are held not only by society but can be internalised by 
those who themselves use substances or experience mental health problems (self-
stigma). Shame has been described as the “emotional core of self-stigma” (Luoma, 
Kohlenberg, Hayes & Fletcher, 2012; p. 43). When a person identifies with more than 
one socially stigmatised group, it is hypothesised that the self-stigma and shame 
from one identity “layers” on top of that related to another identiy, creating a “dense 
web of ideas about the self that must be managed and responded to” (Luoma, 2010; 
p. 1202). It can therefore be hypothesised that  those who have both co-existing 
mental health and substance use problems have the potential to experience higher 
and  more problematic, more distressing levels of shame leading to a greater impact 
than that of either problem in isolation. 
2.3 The relationship between shame and mental health problems 
High levels of shame have been positivley correlated with a range of mental 
health problems, including depression (Cheung, Gilbert, & Irons, 2004; Kim, 
Thibodeau & Jorgensen, 2011), social anxiety disorder (Michail & Birchwood, 2013) 
and eating disorders (Troop & Redshaw, 2012).  
Compared to controls, higher levels of shame have been found in individuals 
with anhedonic schizophrenia (Suslow, Roestel,Ohrmann & Arolt, 2003) and in 
people with first-episode psychosis who were also experiencing social anxiety 
(Michail & Birchwood, 2013). Positive correlational relationships have been observed 
between shame and 1) post-psychotic depression in first episode psychosis 
(Upthegrove, Ross, Brunet, McCollum & Jones, 2014), 2) paranoia, depression and 
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anxiety in a clinical sample of young people at risk of developing psychosis (Johnson, 
Jones, Lin, Wood et al., 2014), and 3) delusional beliefs in a clinical sample of people 
with psychosis-related disorders (Barratt, 2015). 
Furthermore, there is emerging evidence that shame may have a mediating or 
moderating role in psychological difficulties (Hasson-Ohayon et al., 2012; Johnson et 
al., 2014; Rice & Fallon, 2012). For example, in a clinical sample of young people at 
risk of psychosis, shame moderated the the association between stress and paranoia. 
For high shame individuals, shame amplified the association between stress and 
paranoia, but for individuals who scored low on shame, the association between 
stress and paranoia was no longer significant (Johnson et al., 2014).  
In addition to the potential consequences of shame on psychological 
outcomes, shame also plays a role in delaying help-seeking. When shame is evoked 
in those seeking help for illness, potentially through the mechanisms of self-stigma or 
fear of enacted stigma, it is likley to motivate self-concealment (Jones & Crossley, 
2008). Forsell (2006) found shame to be the most common reason for not seeking 
help for psychiatric problems, and higher levels of shame have been associated with 
more negative views of help-seeking (Rusch, Müller, Ajdacic-Gross, Rodgers et al., 
2013). With potential for shame to lead to poorer psychological outcomes and 
possible reluctance to seek help, it is important to consider the role of shame in the 
context of co-exsiting mental health and substance use problems; which is currently 






2.4 The relationship between shame and substance use 
The literature examining the role of shame within the field of substance use is 
less extensive than the mental health focused literature; however there is some 
evidence to suggest that shame is also positively associated with problematic 
substance use. In a sample of college students, higher levels of shame have been 
associated with problematic alcohol use (Dearing, Stuewig & Price-Tangney, 2005). 
In the same study, amongst prison inmates shame was positively correlated with 
alcohol and drug problems, alcohol and drug dependence, and frequency of cocaine 
use (but not with frequency of alcohol or cannabis use). Treeby and Bruno (2012) 
found that shame-prone university students were more likely to experience alcohol 
related problems and were more motivated to use alcohol to cope with depression 
and anxiety. 
The relationship between shame and substance use is clinically controversial, 
and whether shame is an antecedent to substance use or consequence of use is 
unclear from current evidence.  Many people with substance use disorders 
experience shame as a result of behaviours associated with their use; however there 
is also evidence to suggest that shame evokes substance use, as a possible method 
of regulating the negative affect associated with shame (Luoma, 2010). It is possible 
that there is a synergistic relationship whereby shame and substance use lead to a 
vicious cycle (Dearing et al., 2005). For example, substance use may begin as an 
attempt to suppress negative emotions (such as shame), however the substance use 
itself may create more shame and self-stigma, resulting in the person using more 
substances to supress these feelings. Additionally the shame and stigma of being a 
‘substance user’ may lead people to avoid applying for jobs or avoid intimate social 
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relationships because, as a result of self-stigma, people no longer trust themselves to 
fulfill these roles or fear rejection based on their substance-using identity (Luoma, 
2010). Opportunities to disprove their beliefs or elicit compassion within others may 
become limited, further maintaining their experience of shame and in turn their 
substance use.  
Whilst shame has been shown to be an important factor in the experience of 
both mental health and substance use problems, on the other hand the concept of 
psychological flexibility has been postulated as a mechanism that allows individuals 
to respond adaptively to unpleasant and unwanted feelings, for example shame, in 
the context of both mental health and substance use.  
2.5 Psychological flexibility in mental health and substance use problems 
Psychological flexibility is defined as the tendency to respond to unwanted 
internal experiences (thoughts, emotions, memories) in an accepting, mindful, 
defused manner, which allows for engagement in behaviour that serves chosen goals 
(Hayes, Luoma, Bond, Masuda, & Lillis, 2006). The postulated opposite state, 
experiential avoidance (or low psychological flexibility), is therefore an unwillingness 
to experience these unwanted internal experiences in the present moment, resulting 
in the person taking steps to attempt to suppress or control such states (Dinis et al., 
2015). These attempts often include various forms of avoidance, and do not only 
paradoxically increase the occurrence of such events over time, but result in the 
person sacrificing opportunities to work towards their values or goals.  
Low psychological flexibility (or experiential avoidance) has been implicated in 
both mental health and substance use problems. A significant positive correlation 
between experiential avoidance and symptoms of depression has been 
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demonstrated within a general population sample (Dinis et al., 2015) and within a 
clinical sample of people with psychosis (White, Gumley, McTaggart, Rattrie et al., 
2012). Research has highlighted a mediating role of experiential avoidance, for 
example between childhood psychological abuse and current mental health 
symptoms (Reddy, Pickett & Orcull, 2006), and between shame memories and 
depression (Dinis et al., 2015). Psychological flexibility has also moderated treatment 
effects; with higher levels of psychological flexibility leading to enhanced intervention 
outcomes in a workplace intervention (Bond, Flaxman & Bunce, 2008) and in an 
intervention targeting stigma in students (Masuda, Hayes, Fletcher, Seignourel et al., 
2007). Within clinical samples, psychological flexibility has been found to moderate a 
mediated relationship between negative schemas and delusional ideation via mood 
(Oliver, O’Connor, Jose, McLachlan & Peters, 2011).  
Experiential avoidance has also been proposed as a risk and maintenance 
factor for substance use, whereby individuals with low psychological flexibility may 
use substances to avoid and suppress shame and other negative emotions. Levin et 
al., (2012) found a significant difference in experiential avoidance between students 
who used alcohol problematically and those who did not. Within a regression model, 
experiential avoidance was related to more alcohol-related problems. Furthermore, 
psychological distress was initially a significant predictor of alcohol problems, 
however once experiential avoidance was added to the model the relationship 
between distress and alcohol problems was no longer significant. This suggests that 
the relationship between psychological distress and problematic alcohol use can be 
accounted for by experiential avoidance.  
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Not only does psychological flexibility have a potential role in the development 
and maintainence of both mental health and substance use problems, it may also 
have an impact on treatment engagment and oucome. For example, Stotts, 
Vujanovic, Heads, Suchting et al., (2015) compared people within addiction treatment 
services who had responded to a contingency management programme with those 
who had not responded to treatment. The two groups reported similar levels of 
negative affect, impulsivity and cravings; however, those who did not respond to 
treatment displayed higher levels of experiential avoidance.  
2.6 Limitations of current research 
The literature to date indicates that both shame and psychological flexibility 
play a role in the development and maintainence of mental health and substance use 
problems independently, and that both of these concepts may impact on treatment 
engagmement or outcome. There are two important limitations to the current 
evidence base.  
First, the research is limited by use of general population or student samples 
(Dearing, Stuewig & Price-Tangney, 2005; Dinis et al., 2015; Levin et al., 2012; 
Reddy, Pickett & Orcutt, 2006Treeby & Bruno, 2012). Within these samples the 
severity of mental health or substance use problems are generally below that seen 
within clincial samples and participants often fail to meet diagnostic levels. Dearing, 
Stuewig & Price-Tangney (2005) demonstrated that shame had a different role in a 
student and a prison sample, highlighting the importance of studying this relationship 
across different populations.  
Second, the literature on substance use within clinical samples often fails to 
consider mental health problems, and vice versa, despite high levels of co-
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occurrence and the complex nature of the relationship between these two problems, 
particulalry within secondary services. For example, in the study by Johnson et al., 
(2014), the authors made no reference to substance use in a sample where the use 
of substances, particularly cannabis, was likely to be prevalent (e.g. Patel, Wilson, 
Jackson, Ball et al., 2016). Based on the literature reviewed, it is possible that adding 
substance use to the model may have affected the nature of the relationship between 
shame, stress and paranoia. 
2.7 Aims and hypotheses of the current study  
Despite the emerging evidence on shame for people with either mental health 
or substance use problems, there is to date limited research on the experience of 
shame in those with co-occurring substance use and severe mental health problems. 
This includes an exploration of not only a general or global sense of shame, but also 
an exploration of shame specific to the person’s substance use. Shame may 
potentially play a role in the development and maintenance of these complex 
problems and needs to be further understood in this client group. Furthermore, how 
individual levels of psychological flexibility may impact on the relationship between 
psychological problems, shame and substance use also needs to be explored in 
order to establish whether it is an important factor in the potential improvement or 
resolution of negative consequences.  
With these points in mind, the current study had two broad aims; 1) to explore 
the role of shame in people with severe mental health problems who also use 
substances, and 2) to explore the potential role of psychological flexibility/experiential 
avoidance in the relationship between severe mental health problems, shame and 
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substance use. Three more specific hypotheses were formulated based on previous 
literature and tested:  
Hypothesis 1: There will be a positive correlation between psychological distress and 
substance use.  
Hypothesis 2: The relationship between psychological distress and substance use 
will be mediated by shame (both a global sense of shame and shame in relation to 
substance use).    
Hypothesis 3: The mediated effect of shame on the relationship between 
psychological distress and substance use will be moderated by psychological 


















A cross-sectional questionnaire study was used to explore the associations 
between mental health, substance use, shame and psychological flexibility in people 
with severe mental health problems admitted to inpatient units.   Planned analyses 
included correlational as well as exploratory mediation and moderation analyses. The 
study was reviewed and given ethical approval by the UK South Birmingham 
Research Ethics Committee on 01.12.15 (reference: 15/WM/0416; see Appendix 4). 
3.2 Participants 
The sample size was calculated with reference to the mediation analysis. 
Using the bias-corrected and accelerated bootstrap method for a mediation analysis 
(Preacher, Rucker & Hayes, 2007) a sample size of 71 is needed to identify a 
medium effect size on the mediated pathway (Fritz & MacKinnon, 2007). 
Participants were recruited from adult acute inpatient wards within an NHS 
Trust in England. Recruitment took place across four acute wards. Participants were 
eligible for the study if they:  
1) were admitted to an acute inpatient ward and had been on the ward for at 
least one week,  
2) had a diagnosis of a severe mental health problem (schizophenia or 
psychosis related disorder, bipolar disorder or major depressive disorder) according 
to ICD-10 criteria,  
3) had used either alcohol or cannabis on at least one occasion in the 30 days 
prior to their admission, and  
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4) were aged 18 or above.  
Alcohol and cannabis were used as the inclusion criteria for substance use as 
these are the two most commonly used substances amongst this client group 
(Graham, Copello, Griffiths et al., 2016; NICE, 2011). The frequency of substance 
use was set to be at least once in the 30 days prior to admission in order to ensure  
that participants experienced recent use, and to yield a sample with varying degrees 
of alcohol and cannabis use. 
Participants were excluded from the study if they:  
1) did not have capacity to consent to a research study, and  
2) required an interpreter (as no funding resources were available for 
interpreters within the study).  
Participants were not excluded from the research based on disability, gender, 
race or nationality, religion or belief, or sexual orientation.  
3.3 Data collection 
Recruitment took place on the acute inpatient ward where the participant was 
receiving treatment. Potential participants were identified from their clinical records 
and new admissions to the wards were screened using the inclusion criteria. If a 
potential participant met all inclusion criteria the ward manager was contacted to 
establish whether or not the exclusion criteria should be applied. If the potential 
participant met all criteria, they were approached by a member of the clinical team on 
the ward and asked if they were willing to meet with the researcher to discuss 
participation in a research project. Participants who agreed were given the 
information sheet (see Appendix 5) and given the opportunity to ask any questions 
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about the research. Potential participants were given at least twenty-four hours to 
consider particpation and they were then visited a second time to establish whether 
or not they wanted to take part in the research. Participants who agreed to take part 
were asked to provide written consent (see Appendix 6) and then took part in the 
assessment process.  
The assessment involved completion of up to seven questionnaires and took 
approximately 45 minutes to complete with the participant.  
3.4 Measures 
A battery of well established and validiated questionnaires was used to 
measure mental health symptoms, shame, psychological flexibility and substance 
use.  
Mental health symptoms 
The Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983; see 
Appendix 7) was used to assess mental health symptoms. The BSI is a 53-item 
measure of psychological symptoms and has nine subscales (somatization, 
obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility, phobic 
anxiety, paranoid ideation and psychoticism). The BSI also includes three indices of 
global distress. The Global Severity Index (GSI) measures the overall distress level 
and is calculated by dividing the summed total by the number of responses. The 
Positive Symptom Total (PST) measures the number of self-reported symptoms and 
is derived from counting the number of items endorsed with a positive response. The 
Positive Symptom Distress Index (PDSI) measures the intensity of the symptoms and 
is calculated by dividing the sum of the item values by the PST. The BSI has strong 
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internal consistency (α=.97) and there is normative data for adult psychiatric 
inpatients; the GSI mean score and standard deviation for adult psychiatric inpatients 
are 1.19 and 0.86 respectivley (Derogatis & Melisaratos, 1983). 
Shame 
General experience of shame: The Experience of Shame Scale (ESS; 
Andrews, Qian & Valentine, 2002; see Appendix 8) is a 25-item measure that 
assesses three aspects of shame; characterological shame, behavioural shame and 
bodily shame. Total possible scores range from 25 to 100. The measure has good 
internal consistency (α=.92) and test-retest reliability over 11 weeks (r1,2=.83; 
Andrews et al., 2002). 
Substance use related experience of shame: The Substance Abuse Self-
Stigma Scale (SASSS; Luoma, Nobles, Drake, Hayes et al., 2013; see Appendix 9) is 
a 40-item measure of self-stigma and shame in relation to substance abuse. There 
are 3 subscales; self-devaluation, fear of enacted stigma and stigma avoidance/ 
values disengagement. Total scores range from 0 to 200. The overall internal 
consistency is good (α=.86). The original measure was amended slightly for the study 
with permission of the scale author. To make the measure more appropriate for the 
client group, in two items ‘substance abuse’ was amended to ‘substance use’, and for 
4 of the items, the terms ‘substance use problems’ or ‘problems with substances’ 
were amended to ‘substance use’. It is acknowledged that these amendments will 






The Acceptance and Action Questionniare II (AAQ-II; Bond, Hayes, Baer, 
Carpenter et al., 2011; see Appendix 10) is a 7-item, 1-factor measure of 
psychological flexibility or experiential avoidance. Items responses are summed to 
produce a total score of between 0 and 49; with higher scores suggesting greater 
levels of experiential avoidance (and therefore lower levels of psychological flexibility). 
The mean alpha coefficient (from 6 studies including 2,816 participants) is .84 (.78 -
 .88), and the 3 and 12 month test-retest reliability is .81 and .79, respectively (Bond 
et al., 2011).   
Substance Use 
Two measures of substance use were administered that focused on 
consumption and level of problems. The Maudsley Addiction Profile, section B (MAP; 
Marsden, Gossop, Stewart, Best et al., 1998; see Appendix 11) was used to measure 
1) the type of substances used over the past 30 days, 2) the total number of days 
that each substance was used on, 3) the amount used on a typical day, and 4) the 
route of administration. Test-retest reliability for all substances is high, averaging .94 
(Marsden et al., 1998).  
The Alcohol Use Disorder Identification Test (AUDIT; Saunders, Aasland, 
Babor, de la Fuente & Grant, 1993; see Appendix 12) and the The Cannabis Use 
Disorder Identification Test –Revised (CUDIT-R; Adamson, Kay-Lambkin, Baker, 
Lewin et al., 2010; see Appendix 13) were used to assess the level of alcohol and 
cannabis related problems. If the participant had used both alcohol and cannabis in 
the 30 days prior to admission, both of these measures were completed but the 
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participant was asked to identify their primary substance which was then recorded 
and used in further analyses. If the participant had used just one of these substances 
within the time frame, only the applicable measure was completed. The AUDIT is a 
10-item scale measuring recent alcohol use, alcohol dependence symptoms, and 
alcohol-related problems. Total scores range from 0 to 40, with scores of greater than 
8 indicating hazardous or harmful use. The AUDIT is a widely used measure with 
good reliability and validity across a range of settings and populations (Babor, 
Higgins-Biddle, Saunders & Monteiro, 2001). The CUDIT-R is an 8-item scale 
developed along the same principles of the AUDIT and measuring cannabis 
consumption, abuse, dependence and psychological features. Total scores range 
from 0 to 32, again with a score of 8 or above indicating hazardous or harmful use. 
The CUDIT-R was validated within a clinical sample of people with depression and 
co-occuring substance use (Kay-Lambkin, Baker, Lewin & Carr, 2008). It has high 
sensitivity (91%), specificity (90%) and internal consistency (α=.91).  
3.5 Analysis plan 
Data were analysed using SPSS version 23 (IBM Corp, 2014). Data screening 
procedures (Tabachnick & Fidell, 2006) were followed to ensure that the data met 
parametric assumptions for analysis. Univariate and multivariate outliers were 
screened for through calculation of z-scores, examination of box-plots and calculation 
of Malhanobis Distance. Normality of distribution was explored through calculation of 
skewness and kurtosis values, visual inspection of histograms and completion of the 
Shapiro-Wilks test. Homoscedacity was evaluated through visual inspection of 




Descriptive statistics (mean, standard deviation, minimum and maximum 
values) were computed for each outcome measure. A new variable, labelled “level of 
substance use” was computed for each participant using their z-score for the AUDIT 
or CUDIT depending on which substance (alcohol or cannabis) they identified as 
their primary substance. This was done in order to ensure that each participant was 
given a score from either the AUDIT or the CUDIT depending on the main substance 
of use and that scores were comparable across the two measures and on the same 
scale. This variable provided a score for each participant representing the same 
information as both the AUDIT and the CUDIT, i.e. recent use (i.e. frequency and 
amount), dependence symptoms, substance-related problems and psychological 
features associated with use.  
Potential confounding variables including age, gender and ethnicity were 
explored using a series of Pearson’s correlation analyses, t-tests and ANOVAs. 
Representativeness of the sample was considered in two ways; comparison of 
consenters and refusers on demographic variables (age, gender, ethnicity and 
diagnosis), and comparison of consenters to the population as a whole (i.e. all 
inpatient admissions screened) on demographic variables (age, gender and ethnicity).  
Pearson’s correlations were initially calculated to assess the zero-order 
associations between variables of interest (psychological distress, shame, 
psychological flexibility and level of substance use) and to test hypothesis 1. 
Shame was measured in two ways; using the ESS as a global measure of 
shame, and the SASSS as a measure of shame and self-stigma associated with 
substance use. The current evidence base has not explored the correlation between 
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these two measures; and as a result, it is currently difficult to determine whether it is 
reliably possible to examine them as two distinct components of shame, and whether 
or not they are conceptually different from one another. With this in mind, prior to 
conducting the mediation analysis, a variance components analysis was planned to 
explore the degree to which the two variables (general shame and substance use 
related shame) contribute a unique source of variance to the outcome (i.e. level of 
substance use). 
A simple mediation model was used to test hypothesis 2 (Figure 1). This 
model aimed to test the extent to which shame (M) accounts for the relationship 
between psychological distress (X) and level of substance use (Y). Shame would be 
considered a mediator if 1) psychological distress significnatly predicted level of 
substance use, 2) psychological distress significantly predicted shame, and 3) shame 
significantly predicted level of substance use controlling for psychological distress 
(Preacher & Hayes, 2004). When the effect of X on Y decreases to zero with the 
inclusion of M, perfect of full mediation is said to have occurred; when the effect 
decreases but not to zero, partial mediation has occurred (Preacher & Hayes, 2004). 
 





To test hypothesis 3, a moderated mediation analysis was used to establish 
whether psychological flexibility (V) moderated the relationship between shame and 
substance use in this participant group, as presented in Figure 2. This model 
proposes that the indirect effect of the mediated model may vary depending on the 
level of the moderator variable (psychological flexibility). 
 


















4.1 Recruitment to the study 
A total of 49 participants were recruited between April 2016 and March 2017. 
Figure 3 shows the consort diagram for recruitment to the study. Four-hundred and 
forty-two admissions to four wards were screened during the study time frame and 
112 (25%) of these met the study inclusion criteria. Of those who met the criteria, 37 
were discharged before they could be approached to be seen, 26 refused to take part 
and the remaining 49 consented (65% of participants approached). Participants 
refused to take part for several reasons; the most common reasons were that the 
research involved too much work (n=5) or that the participant felt it was not an 
appropriate time for them to take part in a research project (n=5). No participant 
withdrew from the study following 
consent.  

























4.2 Participant characteristics 
Demographic details of the participants recruited are displayed in Table 1. The 
participants were typically male (n=36, 73.5%) with a mean age of 39 (SD=10.34; 
range 21 to 61). Approximately half of the sample were white British (n=26, 53.1%). 
The most frequent diagnosis within the sample was schizophrenia (n=18, 36.7%). 
Eighty-eight percent of the sample had used alcohol in the 30 days prior to admission 
to hospital and 36.7% had used cannabis. 
4.3 Representativeness of the sample 
There was no significant difference between those who consented and those 
who refused to participate in terms of their age (t=-.96, p=.34), gender (ᵡ²=.54, p=.46), 
ethnicity (ᵡ²=2.90, p=.57) or mental health diagnosis (ᵡ²=4.95, p=.22). Those who 
consented to the study did not differ from the population they were recruited from in 
terms of their age (t=.93, p=.35) or their ethnicity (ᵡ²=4.37, p=.50). There was a 
significant difference in terms of gender (ᵡ²=12.52, p<.001), with a higher proportion 

















 Male 36 73.5 
 




 White 26 53.1 
 Asian / Asian British 10 20.4 
 
 Black / Black British 8 16.3 
 
 Mixed 5 10.2 
Mental health diagnosis 
  
 
 Schizophrenia 18 36.7 
 Bipolar Affective Disorder 14 28.6 
 
 Other psychotic disorder 7 14.3 
 
 Schizoaffective Disorder 5 10.2 
 




 Alcohol 43 87.8 
 
 Cannabis 18 36.7 
 Cocaine 6 12.2 
  Crack cocaine 4 8.2 
  New Psychoactive Substances 4 8.2 
  Heroin 2 4.1 
  Amphetamine 1 2.0 
 Primary substance   
  Alcohol 38 77.6 
  Cannabis 11 22.4 
1Participants may have used more than one substance within the 30 days prior to admission 






4.4 Data screening 
Data screening procedures were conducted on the total score for each 
measure employed (BSI, ESS, AAQ, AUDIT, CUDIT, SASSS) and the computed 
“level of substance use” variable. Data met the assumptions for parametric analysis. 
4.5 Descriptive statistics 
Table 2 displays the mean score, the standard deviation and the minimum and 
maximum scores for each of the measures completed. The mean score for the 
sample on the BSI Global Severity Index (GSI) was slightly higher than the normative 
score for psychiatric inpatients (1.19; Derogatis & Melisaratos, 1983); however was 
more comparable to other research studies for psychiatric inpatients that reported 
mean scores of between 1.23 and 1.66 (Kohler, Hoffman, Fydrich et al., 2013; 
Piersma, Reaume & Bues, 1994). The mean score on the ESS was comparable to 
the mean score in a similar sample of people with psychosis (56.87; Barratt, 2015) 
and higher than the mean score reported in a general population sample (47.52; 
Matos, Pinto-Gouveia & Gilbert, 2013). The mean AAQ score was lower than mean 
scores (33.3 to 45.5) previously reported in similar samples (Broten, 2013; Gaudiano, 
Busch, Wenze, Nowlan, et al., 2015; Gumley, White, Briggs, Ford et al., 2016; 
Petersen & Zettle, 2009; White, Gumley, McTaggart, Rattrie et al., 2011;). The mean 
score on the AUDIT was slightly lower than in a similar sample (Graham et al., 2016); 
however this was to be expected as the inclusion criteria in Graham et al., (2016) 
study was for ‘problematic substance use’, as opposed to any level of use within the 
previous month as was defined within the current study. To date, a mean score of the 
CUDIT-R in a similar sample to the current one is not available; however the mean 
score in the current sample is higher than the mean score within a non-treatment 
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seeking sample of cannabis users (9.6; Bruno, Marshall & Adamson, 2013). Although 
the current study did not aim to recruit only participants with “problematic” levels of 
substance use, on average, the mean scores for both the AUDIT and CUDIT would 
fall within this category (Adamson et al., 2010; Saunders et al., 1993). 
Table 2. Descriptive statistics for outcome variables 
Measure 
 
N Mean SD Min Max 
Brief Symptom Inventory (BSI) Global 
Severity Index (GSI) 
49 1.34 .769 0 3 
Experience of Shame Scale (ESS) 49 58.06 18.93 25 97 
Acceptance and Action Questionnaire 49 27.65 11.63 7 49 
Maudsley Addiction Profile (MAP)      
 
Number of days used alcohol 43 17.40 11.31 1 30 
 
Alcohol units consumed per day 43 16.30 19.17 1 90 
 
Number of days used cannabis 18 12.56 11.81 1 30 
 
Cost of cannabis per day (£) 17 11.71 8.11 2 35 
Alcohol Use Disorders Identification Test    
(AUDIT) 
42 16.31 9.94 1 35 
Cannabis Use Disorders Identification 
Test (CUDIT) 
18 13.72 7.27 4 31 
Level of substance use (Z score) 49 .19 .974 -1 2 
Substance Abuse Self Stigma Scale 48 102.39 29.23 50 161 
 
4.6 Confounding variables 
There was no significant correlation between age and any of the total scores 
on the outcome measures. There were also no significant differences between 
ethnicities on any of the outcomes. There was a significant gender difference on the 
AAQ (t(47)=-2.181; p=.03), with females scoring significantly higher scores 
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(mean=33.46, SD=11.87) compared to males (mean=25.56, SD=10.97). No other 
significant gender differences were observed. 
4.7 Pearson’s correlations 
Pearson’s correlations (Table 3) were used to examine the relationships 
between the variables. The relationships between psychological distress (BSI), 
shame (ESS), experiential avoidance (AAQ), level of substance use (computed z 
score of AUDIT and CUDIT scores) and substance use related shame (SASSS) were 
all positive and all significant; suggesting that an increase on one of these measures 
correlates to an increase on another.  




ESS AAQ Substance 
Use 
SASSS 
BSI (GSI) 1 .679** .723** .513** .529** 
ESS 
 










   
1 
**. Correlation is significant at the 0.01 level (2-tailed). *. Correlation is significant at the 0.05 level (2-tailed). 
 
4.7 Hypothesis 1: There will be a positive correlation between psychological 
distress and level of substance use.  
As presented in Table 3, Pearson’s r indicates that there was a significant and 
positive correlation between psychological distress and level of substance use 
(r=.513; p<.001). This suggests that an increase in psychological distress is 
associated with an increase in substance use.   
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4.8 Hypothesis 2: The relationship between psychological distress and 
substance use will be mediated by shame (both a global sense of shame and 
shame in relation to substance use).    
4.8.1 Variance components analysis 
As described in the method section, prior to conducting the mediation analysis, 
a variance components analysis was planned to explore the degree to which the two 
shame variables (general shame measured by the ESS and substance use related 
shame and self-stigma measured by the SASSS) contributed a unique source of 
variance to the outcome (i.e. level of substance use) and, therefore, represent 
orthogonal dimensions of shame.  
A linear regression model confirmed that each predictor variable (ESS and 
SASSS) was independently contributing to explaining the variance in substance use; 
with the SASSS explaining 51% of the variance (R2=.51, F(1,46)=48.24, p<.001) and 
the ESS explaining 37% of the variance (R2=.37, F(1,47)=28.07, p<.001) when each 
variable was independently regressed to substance use. 
A hierarchical regression model was used to assess the unique contribution of 
each predictor (ESS and SASSS) to substance use over and above the variance 
shared between the two measures of shame. The SASSS was entered into the 
model on step 1 as it had the strongest relationship with the outcome variable and 
explained more of the variance in the previous model, followed by the ESS in step 2. 
The results of the hierarchical regression (Table 4) suggest that step 1 accounted for 
51% of the variance in substance use (R2=.51, f(1,46)=48.24, p<.001), whilst step 2 
accounted for 54% of the variance (R2=.54, f(2,45)=27.05, p<.001); an increase of 
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3%. The ESS is therefore providing 3% of unique variance. The regression was 
repeated with the ESS entered at step 1 and the SASSS at step 2 to determine the 
unique contribution of the SASSS.  
Table 4. Hierarchical regression model to substance use 
 b SE b Β 
Step 1    
 Constant -2.272 .369  
 SASSS .024 .003 .715** 
Step 2    
 Constant -2.430 .370  
 SASSS .018 .005 .534** 
 ESS .014 .007 .259 
R2 = 0.51 for step 1; R2 = 0.54 for step 2. 
The Venn diagram (Figure 4) shows the amount of variance in substance use 
explained by substance use related shame independently (SASSS; A), by global 
shame independently (ESS; C) and by the shared variance between the SASSS and 
the ESS (B). As shown in Figure 4, a large part of the variance in substance use 
explained by the hierarchical regression model is shared between the contributions of 
general shame and substance related shame (37%), with both constructs 
contributing only a small amount independently of one another. With this is mind, it 
cannot be concluded that the ESS and the SASSS are measuring two unique and 
distinct concepts and therefore, as they cannot be assumed to be conceptually 
different from one another, they cannot be entered into the mediation analysis as two 
separate measures. At this stage, both measures of shame (ESS and SASSS) were 
combined by adding the total score of each together for each participant; therefore, 
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producing a single measurement of the construct, which was then labelled as 
“shame”. This measure was used in the following mediation analysis. 
 
Figure 4. Venn diagram of shared variance 
 
4.8.2 Mediation analysis 
Regression analysis was used to investigate the hypothesis that shame 
mediates the effect of psychological distress on substance use (Figure 5). The total 
effect model (c; in the absence of the mediator) indicated that psychological distress 
was a significant predictor of substance use (b=.755, SE=.165, p<.001), with 



































Figure 5. The mediating effect of shame 
 
When the mediator variable (shame) was added to the model, the results 
indicated that psychological distress was a significant predictor of shame (b=38.158, 
SE=6.996, p<.001), and that shame was a significant predictor of substance use 
(b=.014, SE=.003, p< .001). These results support the mediational hypothesis. The 
variance in substance use explained by the total effects model fell by 71% when 
controlling for shame; from 31% to 9%. Although this did not reach zero; 
psychological distress was no longer a significant predictor of substance use after 
controlling for shame (the mediator; b=.215, SE=.171, p=.215), consistent with full 
mediation. In other words, the effect of psychological distress on substance use is 
fully mediated by shame. The mediated model accounted for 56% of the variation in 
substance use, an increase of 25% compared to the total effect model. 
4.9 Hypothesis 3: The mediated effect of shame on the relationship between 
psychological distress and substance use, will be moderated by psychological 
flexibility (representing a moderated mediation effect). 
In order to test this hypothesis, the conditional indirect effect of psychological 




a (b = 38.15; 95% CI 
= 24.07 – 52.24) 
Substance use  
b (b = .01; 95% CI = .01 
- .02) 
c’ (b = .22; 95% CI = -.13 - .56) 
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psychological flexibility using the PROCESS macro on SPSS (Preacher, Rucker & 
Hayes, 2007). Psychological flexibility did not significantly moderate the association 
between shame and substance misuse, implying that the indirect effect of shame on 
level of substance use was not higher or lower depending on psychological flexibility 






















Substance use  
b = .0003; 95% CI 






5.1 Summary of study results 
The current study aimed to explore the role of the experience of shame and 
psychological flexibility in the relationship between psychological distress and 
substance use amongst a clinical sample of people with severe and enduring mental 
health problems (psychotic disorders, bipolar affective disorder and major depressive 
disorders). Based on previous research, it was hypothesised that there would be a 
relationship between psychological distress and substance use, and that this 
relationship would be mediated by shame. Furthermore, it was hypothesised that this 
mediated relationship would be moderated by psychological flexibility. 
The results highlighted that there was a significant and positive relationship 
between psychological distress and substance use in line with the predicted 
hypothesis, showing that an increase in psychological distress was associated with 
an increase in substance use. When hypothesis two was explored, it was found that 
this relationship was mediated by shame, instead suggesting a different path through 
which increased psychological distress was associated with increased shame, which 
in turn was associated with increased substance use.  Psychological flexibility was 
not found to moderate this mediated relationship, suggesting that higher levels of 
psychological flexibility did not reduce the impact of shame on substance use; the 
third hypothesis was therefore not supported within this study.  The results are further 





5.2 Representativeness of the sample 
The participants recruited to the study were typically male, approximately half 
were white British and the most common diagnosis was schizophrenia. A comparison 
across demographic variables of both those who consented to those who refused, as 
well as those who consented to the entire population from which participants were 
recruited, suggested that the sample was, on the whole, representative of both those 
eligible and the wider population of inpatient admissions. Although there was no 
significant gender difference between those who consented and those who refused, 
there was a gender difference between those who consented (the sample) and the 
entire population of admissions screened.  This is unsurprising when considering the 
inclusion criteria for the study, as there is evidence to suggest that males are more 
likely than females to have a diagnosis of schizophrenia (Iacono & Beiser, 1992; 
Ochoa, Usall, Cobo, Labad & Kulkarni, 2012) and also to use alcohol and drugs 
(Substance Abuse and Mental Health Services Administration, 2014). Although this 
gender difference could potentially introduce bias to the results, the finding that there 
was no significant gender difference between those who consented and those who 
refused implies that, of those meeting the inclusion criteria for the study, the results 
were representative in terms of gender. This therefore increases the external validity 
of the study and makes the results more generalizable to this particular client group.  
Previous research had shown that females report higher levels of shame than 
males across different populations (Wiklander et al., 2012); this finding was not 
replicated within this sample, where males expressed comparable levels of shame to 
females. Previous research has also shown a negative correlation between shame 
and age (Wiklander et al., 2012), again a finding that was not replicated within this 
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study sample. It is important to acknowledge that, based on these findings, high 
levels of shame can be experienced by people within this client group regardless of 
their age, gender or ethnicity. Whilst levels of psychological flexibility did not differ 
across age or ethnicity, females scored significantly higher on the AAQ than males, 
suggesting lower levels of psychological flexibility (or higher levels of experiential 
avoidance) amongst females. This is in contrast to previous findings (Bond et al., 
2011; Dinis et al., 2015) that reported no gender difference in experiential avoidance 
within samples recruited from the general population, student populations and a 
treatment seeking population of substance users.  The present results suggest a 
gender difference in this complex population and therefore psychological flexibility 
amongst people with co-existing mental health problems and substance use requires 
further exploration. 
5.3 Shame and Psychological Flexibility 
As discussed in the introduction, the present study aimed to focus on a group 
of people with complex and co-existing needs related to mental health and substance 
use, and therefore makes a contribution to this area that has tended to be overlooked 
in previous research literature. One of the original aims, having established from 
previous evidence that the experience of shame was relevant to both mental health 
and substance use separately, was to explore the contribution of a global sense of 
shame as well as a more specific substance use related shame within a group with 
co-existing problems. The two originally identified measures of shame (Andrews, 
Qian & Valentine, 2002; Luoma et al., 2013) were therefore selected from the 
research literature on the assumption that they would each tap into distinctive 
aspects of the shame experience; either adding different variance in the test or one 
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being more important than the other within this population. Once the data were 
collected however and subjected to the initial analyses, it was found that there was a 
highly significant level of correlation between the two separate shame measures with 
only a very small amount of variance explained by each separately. This suggests 
that even though the two measures are presented as being empirically different, we 
may conclude from the present study that the experience of both a global sense of 
shame and shame in relation to substance use as currently measured, share more 
commonality than difference and that our ability to empirically separate the two 
experiences of shame is limited at present.   
Whist the separation of two conceptually distinct experiences of shame proved 
to be not possible, the findings through combining both measures suggested 
nevertheless that the overall experience of shame was a significant factor in the 
relationship between psychological distress and substance use. Whist the precise 
mechanism is difficult to ascertain from the present findings, it remains an important 
area for both future research and practical treatment focus that may benefit from 
further exploration with, for example, longitudinal designs. The extent to which 
substance use adds to the overall experience of shame that has been documented in 
mental health samples, remains unclear. 
An additional aim of the study was to explore the potential moderating effect of 
psychological flexibility on the relationship between shame and substance use, which 
was not supported. One possible explanation for this is a lack of power to detect an 
effect due to the relatively small sample size, as a moderated-mediation model 
requires a larger number of participants given the increased number of paths tested. 
An alternative interpretation is that psychologically flexibility within this sample was 
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higher than what has been reported in similar samples, and there is evidence to 
suggest that psychological flexibility may be more influential at lower levels. For 
example, Masuda et al., (2007) reported that Acceptance and Commitment Therapy 
had superior outcomes compared to a control intervention for people with lower 
levels of psychological flexibility, but there was no difference in outcomes between 
groups for those with higher levels of psychological flexibility.  
5.4 Limitations 
Potential limitations of the current research relate to study design, sample size 
and measurement. The study utilised a cross-sectional design, which limits the extent 
to which causal interpretations can be made regarding the study findings. The initial 
power calculation indicated that 71 participants were required to detect a medium 
effect using the bias-corrected bootstrap mediation model when both paths 
(psychological distress to shame, and shame to substance use) produced a medium 
effect size (Fritz & MacKinnon, 2007). Recruitment of this sample proved challenging 
given the fact that the study group involved those admitted to acute inpatient services 
where typically the admission period was brief, and so often potential participants 
were discharged before being seen by the researcher. A number of potential 
participants also refused to take part, for example if they felt that the research 
involved too much work, further limiting the sample size. The expected sample size 
was therefore not fully achieved. However, given the finding of significance in the 
mediation analysis, it is possible to propose that the sample obtained was adequate 
to test the mediation model. In comparison to the mediation model, the moderated 
mediation model included several additional regression paths; indicating a need for a 
larger sample size to detect an effect within this model. With this is mind, the 
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moderated mediation analysis might have been considerably underpowered within 
the current study.  
Measurement of shame and substance use posed some challenges that need 
to be considered in future studies. Those related to the specificity and measurement 
of shame have been already discussed. The measurement of substance use and 
related problems also posed some challenges. Despite the conceptual and 
theoretical ways in which various substances, or indeed substance and non-
substance related addictions, have been seen as having clear commonalities (e.g. 
Orford, 2001), measurement appears to lag behind with most existing questionnaires 
focused on a single, specific substance (i.e. alcohol or cannabis). Whilst generic 
measures of serious dependence are available and can be completed irrespective 
the specific substance (e.g. Severity of Dependence Scale; Gossop, Darke, Griffiths, 
Hando, Powis, et al., 1995), when attempting to measure infrequent and lower levels 
of use as well as higher, more dependent levels of use, such as those displayed in 
this sample, this becomes a challenge. Given that alcohol and cannabis are the most 
common substances used by this population, and that the current study therefore 
aimed to include both, the only alternative measure that could have been considered 
was the ASSIST (Humeniuk, Ali, Babor, Farrell, Formigoni, et al., 2008). This 
measure however was developed for young people and was considered less relevant 
and reliable for the current sample than the AUDIT and the CUDIT. The strategy 
adopted in this study to be able to equate one substance with another (i.e. alcohol 
with cannabis) was to use standardised z-scores from the AUDIT and CUDIT in order 
to make them comparable across both substances, and to use the relevant score 
depending on which was the main substance used as reported by the participant.  
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5.5 Clinical and future research implications 
The present results suggest that, when working with those experiencing 
combined mental health problems and substance use, targeting shame constitutes 
an important focus for psychological interventions. Targeting shame therapeutically 
may contribute towards breaking or at least impacting on the relationship between 
mental health and substance use.  
Acceptance and Commitment therapy (ACT) is a psychological approach that 
can help people to become more mindful of stigmatizing and shaming thoughts and 
evaluations (Luoma, 2010), and to develop strategies to increase acceptance of them.  
ACT postulates that by developing an ability to “defuse” from such evaluations (i.e. to 
see a thought as just a product of our busy minds), the individual increases their 
psychological flexibility and is more able to engage in value-driven activity, rather 
than getting caught-up in and attempting to suppress or avoid such evaluations or 
emotional states (for example through the use of substances). 
Luoma et al., (2012) reported a randomised controlled trial that compared an 
ACT intervention specifically targeting shame to treatment as usual in a residential 
substance use treatment centre. At follow-up those who received the ACT 
intervention showed significantly lower levels of shame, and were also less likely to 
have used substances during the follow-up period. As previously highlighted, the 
evidence base examining the role of shame substance use often fails to consider the 
role of mental health, and vice versa.  It is unclear in the study by Luoma et al., 
(2012) how many participants within this sample had a mental health diagnosis or 
what the possible diagnoses were. There is also to date an absence of evidence 
evaluating ACT for shame within mental health populations or importantly for people 
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with co-existing mental health and substance use problems. A prospective 
longitudinal intervention study evaluating ACT for this client group is recommended. 
It would be important to measure shame at pre-intervention, post-intervention and 
longer-term follow-up. The intervention could be compared to ‘treatment as usual’ or 
an active intervention condition, such as CBT, or ideally both.   
This research would be an important next step, and with the mediation model 
presented in the current study in mind, it would be not only important to evaluate 
such an intervention in terms of its impact on shame, but also to consider and draw 
attention to the processes of change during such interventions (i.e. do changes in 
shame correlate to changes in substance use?). It has been suggested that mixed 
results in treatment trials are potentially caused by the presence of unrecognised 
mediating or moderating factors (Johnson et al., 2014). Shame may fit into this 
category, and it is imporant to consider this when evaluating interventions for this 
client group. 
Whilst the current paper focused on substance use as the outcome, it is also 
important to consider the evidence base more broadly and think about the clinical 
implications of the research in terms of additional outcomes for this client group. For 
example, it is well documented that this client group experience higher rates of 
reoccurrence of problems, increased rates of hospitalisation and are often less 
engaged in treatment programmes. The shame literature highlights that a fear of 
help-seeking due to feelings of shame or anticipation of enacted stigma may 
decrease motivation to ask for help, and therefore contribute to the above outcomes 
(Luoma, 2010). Reducing shame through psychological interventions may enable 
100 
 
people to seek help at an earlier stage, become more engaged in the treatment 
process and maybe even avoid admission to hospital. 
5.6 Conclusion 
Substance use, particularly use of alcohol, is prevalent amongst people with 
severe and enduring mental health problems admitted to acute inpatient wards. 
Shame is an important factor to consider when working with people with severe and 
enduring mental health problems who are also using substances and may influence 
the relationship between psychological distress and substance use. When working 
with this client group, targeting shame may therefore be an important goal for 
psychological interventions. The role of psychological flexibility in the relationship 
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Chapter III: Public Dissemination Document 
 
























Serious and persistent mental health problems, also described as severe and 
enduring, are long-lasting mental health problems that can have a very large impact 
on a person’s life. They usually include diagnoses such as schizophrenia and 
psychosis-related diagnoses, bipolar affective disorder and major depression. Severe 
and enduring mental health problems can increase the risk of poor outcomes such as 
mental health relapses and admission to hospital, social exclusion, discrimination 
and loneliness, all shown in previous research studies.  The prevalence of alcohol 
and drug use amongst this client group is high (NICE, 2011), which also increases 
some of these risks. 
It is therefore extremely important that effective psychological interventions are 
available for this group of people. Currently, Cognitive-Behavioural Therapy (CBT) is 
the psychological intervention that is recommended by the National Institute of 
Clinical Excellence (e.g. NICE, 2014), however, some suggest that the evidence for 
CBT has been “oversold” (e.g. Jones, Hacker, Cormack et al, 2012) and that perhaps 
alternative therapies should be explored. 
The present thesis attempts to contribute to the evidence in two ways. First, it 
considers one of these alternative therapies for people with severe and enduring 
mental health problems. It does this by reviewing published research to date that has 
evaluated a specific therapy, Acceptance and Commitment Therapy (ACT), for this 
client group. Second, it reports an original empirical research paper that considers 
why change may occur for people with severe and enduring mental health problems 
who also use substances (alcohol or cannabis). It does this by looking at two 
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important factors that might influence the relationship between psychological distress 
and substance use (and therefore be important targets for psychological 



















2. Chapter I: Literature review 
Title: Acceptance and Commitment Therapy (ACT) for people with severe and 
enduring mental health problems: A meta-analysis 
Introduction: Acceptance and Commitment Therapy (ACT) is a therapeutic 
approach that aims to help people to increase their “psychological flexibility”. 
Psychological flexibility has been defined as a process whereby an individual is able 
to notice and observe inner and private experiences, such as thoughts or emotions, 
and accept these as they are rather than attempting to change them. A reduction in 
mental health symptoms is not the primary goal of ACT, instead, ACT attempts to 
change a person’s relationship with their inner experience, rather than changing the 
experience itself.  
Research trials have found that ACT can be helpful for people with a range of 
physical and mental health problems, for example stress, anxiety, smoking, weight 
loss and pain (Association for Contextual Behavioural Science, 2015). Research has 
also begun to evaluate ACT for severe and enduring mental health problems. The 
current literature review aimed to bring together the research on ACT for this client 
group and evaluate whether or not it might be a helpful therapeutic intervention. 
Method: A search for relevant research was conducted using electronic 
databases and by contacting key authors in the ACT field. Twelve research trials that 
evaluated ACT for people with severe and enduring mental health problems were 
identified. These trials were then combined using a technique called meta-analysis; a 
statistical procedure that allows information from different trials to be combined to 
reach a single conclusion. The review explored four different outcomes and looked at 
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whether ACT, in comparison to a person’s usual care or another intervention (i.e. the 
control condition), had an impact on 1) symptoms of psychosis, 2) symptoms of 
depression, 3) psychological flexibility and 4) admission to hospital.  
Main results: The results suggested that ACT had no beneficial effect on 
symptoms of psychosis compared to the control group either immediately after the 
intervention or at follow-up a few months later. The results suggested that those who 
received ACT reported fewer symptoms of depression after the intervention than 
those who received the control condition; and this improvement was maintained at 
follow-up. Regarding psychological flexibility, the results suggested that the 
intervention increased psychological flexibility compared to the control group 
immediately after therapy, however this had decreased again by follow-up. Finally, 
ACT did not significantly reduce the risk of admission to hospital compared to the 
control group.  
 Conclusion: The question of whether or not ACT is an effective treatment for 
people with severe and enduring mental health problems is a difficult one to answer 
with certainty at this current stage of evidence. The answer, in part, depends on what 
indicates that an intervention is successful. If a reduction in symptoms is the aim, 
then the current review suggests that ACT is useful in decreasing symptoms of 
depression, but not symptoms of psychosis. If the target of the intervention is to 
increase psychological flexibility, then the current review provides some evidence 
that ACT can increase psychological flexibility in the short term. If the target of an 
intervention is to attempt to reduce reoccurrence of symptoms and keep people out 
of hospital, an important consideration for this group, then the present results 
suggest that ACT is no more successful than treatment as usual.  
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3. Chapter II: Empirical paper 
Title: An exploration of shame, psychological flexibility and the use of alcohol or 
drugs in people with mental health problems. 
Background: Shame is defined as a powerful self-conscious emotion that often 
leads to a desire to hide or escape. Research has shown that high levels of 
persistent shame are associated with a range of mental health problems and also 
with increased substance use. Research to date however has looked at the role of 
shame in mental health and the role of shame in substance use separately, and has 
not investigated the specific role of shame in people with co-existing mental health 
problems and substance use. This study predicted that shame would help to explain 
the relationship between mental health and substance use. The study also wanted to 
investigate the role of psychological flexibility within this relationship. Previous 
research has suggested that lower levels of psychological flexibility may be 
associated with mental health problems and also with substance use. With this in 
mind, the current study predicted that higher levels of psychological flexibility would 
protect those taking part against the impact of shame. 
Method: People who had been admitted to an inpatient unit were asked to 
take part in the research if they had a mental health diagnosis (bipolar disorder, 
major depression or a psychosis-related diagnosis) and if they had used alcohol or 
cannabis in the month before their admission to hospital. If they agreed to take part in 
the research, the participant completed questionnaires with the researcher. The 
questionnaires asked questions about psychological distress, shame, psychological 
flexibility and alcohol and drug use.   
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Main results: Forty-nine people took part in the research project and 
completed the questionnaires. Participants were typically male (74%), had an 
average age of 37 years and approximately half were white British (53%). The results 
suggested that there is a positive relationship between psychological distress and 
substance use; meaning that typically as psychological distress increases, so does 
substance use. When we think about how shame fits into this relationship, the results 
suggest that high levels of psychological distress lead to high levels of shame, and 
shame can then lead to substance use. The results also suggested that 
psychological flexibility did not influence this relationship, so people with higher levels 
of psychological flexibility were not protected against the impact of shame as it was 
hypothesised.  
Conclusions: Shame is an important factor to consider when working with 
people with severe and enduring mental health problems who also use substances. 
When working with this client group, targeting shame may be an important goal for 
psychological interventions. The role of psychological flexibility in the relationship 









4. Overall Summary 
There is preliminary evidence that shame plays a role in the relationship 
between psychological distress and substance use amongst people with severe and 
enduring mental health problems. There is some evidence that Acceptance and 
Commitment Therapy (ACT) may be a helpful therapeutic approach for people with 
severe mental health problems in terms of increasing psychological flexibility and 
reducing depression. Research trials are yet to evaluate whether ACT can reduce 
feelings of shame amongst people with severe and enduring mental health problems 
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Appendix 1: Outcomes excluded from the analysis 
 
Study Outcome excluded Reason for exclusion 
Bach & Heyes 
(2002) 
Rehospitalisation rate at 12 months N’s not reported 
Gaudino & 
Herbert (2006) 
Self-ratings of psychotic symptoms 
(frequency, believability, and distress) 
Validated measure of psychotic 






White et al 
(2011) 
Kentucky Inventory of Mindfulness Skills Measure of acceptance selected to 
increase consistency within the outcome 
category 
Folke et al 
(2012) 
None  
Shawyer et al 
(2012) 
Self-ratings of psychotic symptoms 




 - Resistance Subscale 
BAVQ
1
 – Engagement Subscale 
 
Validated measure of psychotic 
symptoms included 
Complete measure of the construct 
included over subscales  
Broten (2013) 
 
Beck Depression Inventory (BDI) 
Automatic Thoughts Questionnaire 
Not reported at final follow up point 
Not reported at final follow up point 





Tyrberg et al., 
(2016) 
Bulls-Eye Values Survey 
 
Non-parametric data reported 









Complete measure of the construct 





 Positive Subscale 
PANSS
3
 Negative Subscale 
Self-ratings of psychotic symptoms 
(frequency, believability, and distress) 
 
Data not reported 
 
Validated measure of psychotic 
symptoms included 





Kentucky Inventory of Mindfulness Skills 
 
 
Calgary Depression Scale 
Data not reported 
Measure of acceptance selected to 
increase consistency within the outcome 
category 
BDI selected as measure of depression 




Beliefs about Voices Questionnaire; 
2
Psychotic Symptom Rating Scale; 
3





Appendix 2: Correlation co-efficient used to aggregate outcomes 
 





Bach & Heyes 
(2002) 
Self-ratings of psychotic 
symptoms (frequency, 
believability, distress) 







Petersen & Zettle 
(2009) 




0.73 Beck, (1988) 
White et al (2011) PANSS
1
 Positive Subscale 
PANSS
1




Van Erp, (2014) 
Fulford et al., (2014) 
Folke et al (2012) None 
 
  




 Subscale A  
VAAS
2
 Subscale B 
 
0.3, 0.5, 0.7 None available within 
the literature 
Broten (2013) None 
 
  















Boden et al., 
(2016) 
None   




- positive scale 
PANAS
3
- negative scale 
-0.17 Watson & Clark, (1988) 
1
Positive and Negative Syndrome Scale; 
2
Voices Acceptance and Action Questionnaire; 
3
Positive and 







Appendix 3: The Quality Index (Downs and Black, 1998) 
 




1. Is the hypothesis/aim/objective of the study clearly described? 
 
2. Are the main outcomes to be measured clearly described in the Introduction or 
Methods section? 
If the main outcomes are first mentioned in the Results section, the question should 
be answered no. 
 
3. Are the characteristics of the patients included in the study clearly described? 
In cohort studies and trials, inclusion and/or exclusion criteria should be given. In 
case-control studies, a case-definition and 
the source for controls should be given. 
 
4. Are the interventions of interest clearly described? 
Treatments and placebo (where relevant) that are to be compared should be clearly 
described. 
 
5. Are the distributions of principal confounders in each group of subjects to be 
compared clearly described? 
A list of principal confounders is provided. 
 
6. Are the main findings of the study clearly described? 
Simple outcome data (including denominators and numerators) should be reported 
for all major findings so that the reader can check the major analyses and 
conclusions. 
(This question does not cover statistical tests which are considered below). 
 
7. Does the study provide estimates of the random variability in the data for the main 
outcomes? 
In non-normally distributed data the inter-quartile range of results should be reported. 
In normally distributed data the standard error, standard deviation or confidence 
intervals should be reported. If the distribution of the data is not described, it must be 
assumed that the estimates used were appropriate and the question should be 
answered yes. 
 
8. Have all important adverse events that may be a consequence of the intervention 
been reported? 
This should be answered yes if the study demonstrates that there was a 
comprehensive attempt to measure adverse events. (A list of possible adverse 
events is provided). 
 
9. Have the characteristics of patients lost to follow-up been described? 
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This should be answered yes where there were no losses to follow-up or where 
losses to follow-up were so small that findings would be unaffected by their inclusion. 
This should be answered no where a study does not report the number of patients 
lost to follow-up. 
 
10. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for 




All the following criteria attempt to address the representativeness of the findings of 
the study and whether they may be generalised to the population from which the 
study subjects were derived. 
 
11. Were the subjects asked to participate in the study representative of the entire 
population from which they were recruited? 
The study must identify the source population for patients and describe how the 
patients were selected. Patients would be representative if they comprised the entire 
source population, an unselected sample of consecutive patients, or a random 
sample. Random sampling is only feasible where a list of all members of the relevant 
population exists. Where a study does not report the proportion of the source 
population from which the patients are derived, the question should be answered as 
unable to determine. 
 
12. Were those subjects who were prepared to participate representative of the entire 
population from which they were recruited? 
The proportion of those asked who agreed should be stated. Validation that the 
sample was representative would include 
demonstrating that the distribution of the main confounding factors was the same in 
the study sample and the source population. 
 
13. Were the staff, places, and facilities where the patients were treated, 
representative of the treatment the majority of patients receive? 
For the question to be answered yes the study should demonstrate that the 
intervention was representative of that in use in 
the source population. The question should be answered no if, for example, the 
intervention was undertaken in a specialist 
centre unrepresentative of the hospitals most of the source population would attend. 
 
Internal validity – bias 
 
14. Was an attempt made to blind study subjects to the intervention they have 
received? 
For studies where the patients would have no way of knowing which intervention they 
received, this should be answered yes. 
 





16. If any of the results of the study were based on “data dredging”, was this made 
clear? 
Any analyses that had not been planned at the outset of the study should be clearly 
indicated. If no retrospective unplanned subgroup analyses were reported, then 
answer yes. 
 
17. In trials and cohort studies, do the analyses adjust for different lengths of follow-
up of patients, or in case-control studies, is the time period between the intervention 
and outcome the same for cases and controls? 
Where follow-up was the same for all study patients the answer should yes. If 
different lengths of follow-up were adjusted for by, for example, survival analysis the 
answer should be yes. Studies where differences in follow-up are ignored should be 
answered no. 
 
18. Were the statistical tests used to assess the main outcomes appropriate? 
The statistical techniques used must be appropriate to the data. For example 
nonparametric methods should be used for 
small sample sizes. Where little statistical analysis has been undertaken but where 
there is no evidence of bias, the question 
should be answered yes. If the distribution of the data (normal or not) is not 
described it must be assumed that the estimates used were appropriate and the 
question should be answered yes. 
 
19. Was compliance with the intervention/s reliable? 
Where there was non-compliance with the allocated treatment or where there was 
contamination of one group, the question 
should be answered no. For studies where the effect of any misclassification was 
likely to bias any association to the null, the 
question should be answered yes. 
 
20. Were the main outcome measures used accurate (valid and reliable)? 
For studies where the outcome measures are clearly described, the question should 
be answered yes. For studies which refer to other work or that demonstrates the 
outcome measures are accurate, the question should be answered as yes. 
 
Internal validity - confounding (selection bias) 
 
21. Were the patients in different intervention groups (trials and cohort studies) or 
were the cases and controls (case-control studies) recruited from the same 
population? 
For example, patients for all comparison groups should be selected from the same 
hospital. The question should be answered 
unable to determine for cohort and case control studies where there is no information 




22. Were study subjects in different intervention groups (trials and cohort studies) or 
were the cases and controls (case-control studies) recruited over the same period of 
time? 
For a study which does not specify the time period over which patients were recruited, 
the question should be answered as unable to determine. 
 
23. Were study subjects randomised to intervention groups? 
Studies which state that subjects were randomised should be answered yes except 
where method of randomisation would not 
ensure random allocation. For example alternate allocation would score no because 
it is predictable. 
 
24. Was the randomised intervention assignment concealed from both patients and 
health care staff until recruitment was complete and irrevocable? 
All non-randomised studies should be answered no. If assignment was concealed 
from patients but not from staff, it should 
be answered no. 
 
25. Was there adequate adjustment for confounding in the analyses from which the 
main findings were drawn? 
This question should be answered no for trials if: the main conclusions of the study 
were based on analyses of treatment rather than intention to treat; the distribution of 
known confounders in the different treatment groups was not described; or the 
distribution of known confounders differed between the treatment groups but was not 
taken into account in the analyses. In nonrandomised studies if the effect of the main 
confounders was not investigated or confounding was demonstrated but no 
adjustment was made in the final analyses the question should be answered as no. 
 
26. Were losses of patients to follow-up taken into account? 
If the numbers of patients lost to follow-up are not reported, the question should be 
answered as unable to determine. If the 
proportion lost to follow-up was too small to affect the main findings, the question 




27. Did the study have sufficient power to detect a clinically important effect where 
the probability value for a difference being due to chance is less than 5%? 
































































































































































































































































































































































































































































































































































































































































































Appendix 13: Cannabis Use Disorders Identification Test 
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